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2. Abstract (253 words) 
Background: Prematurity is a major risk factor for morbidity and mortality in children. 
Rehospitalisation with paediatric intensive care unit (PICU) admission constitutes 
significant morbidity. There is a paucity of literature regarding rehospitalisations of 
premature infants in South Africa.  
Objective: To describe the outcomes, clinical course and characteristics of premature 
infants admitted to a South African PICU, and to identify any predictors of mortality.  
Methods: This prospective observational study analysed unplanned PICU admissions of 
premature and ex-premature infants in the first six months of life, over a six-month 
period. The primary and secondary outcomes were mortality and length of PICU stay, 
respectively. Data were analysed using standard descriptive and inferential statistics. 
Results: 29 infants (65% male; median (IQR) birth weight (BW) and gestational age (GA) 
1715 (1130 - 2340) g and 32 (29 - 34) weeks respectively) in 33 admissions were included. 
Five (17.2%) infants died in PICU.  
Apnoea (39.4%), respiratory failure (24.2%) and shock (24.2%) were the commonest 
reasons for PICU admission, secondary to pneumonia (33.3%), sepsis (27.3%) and 
meningitis (12.1%). 72.4% of infants were mechanically ventilated and 48.3% received 
blood transfusions. 
Higher revised Paediatric Risk of Mortality (PIM2) score (p = 0.03), inotrope use (p < 
0.0001), longer duration of mechanical ventilation (p = 0.03), and cardiac arrest in PICU (p 
< 0.0001) were associated with mortality on univariate analysis with no independent 
predictors of mortality.  
Conclusion: Infections leading to apnoea, respiratory failure and shock are common 
indications for PICU readmission in premature infants. Mechanical ventilation and blood 
transfusion were frequently required.  
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6. CHAPTER ONE: BACKGROUND AND LITERATURE REVIEW 
Background 
Prematurity is a major risk factor for morbidity and mortality. According to the World Health 
Organization (WHO), preterm birth complications is the leading cause of death in children 
under-5 years[1]. In a recent review of mortality in children under-5 years of age in the Metro 
West geographical service area of the Western Cape Province, prematurity was found to be 
the third leading cause of death; it accounted for 9.3% of all deaths[2].  
Care of the premature new-born is an ever-evolving paediatric discipline[3]. There have been 
dramatic advancements in the knowledge and interventions related to care of any premature 
infant. Survival is not only a possibility, but most often the expectation, in many situations 
once considered to be futile[4]. However, the risk in these cases is that a premature infant may 
survive with significant morbidity. The consequence of this may mean increased demands on 
the health care system and family in the future. 
Research into the outcome of this growing group of surviving premature infants in low to 
middle income countries is limited; particularly when specifically considering those infants 
who become seriously ill and require readmission in to a neonatal or paediatric intensive care 
unit (PICU). It is critically important to have data that accurately shows the burden of disease 
within this population, as well as any risk factors that are identifiable so as to identify those 
infants who are especially susceptible to increased morbidity and/or mortality.  
Red Cross War Memorial Children’s Hospital (RCWMCH) functions as the tertiary level 
hospital within the Cape Town West Metro District for all children beyond the neonatal 
period. The study was based at this center as it is the only PICU within the public sector for 
this district. Currently there are no published studies reflecting data from South Africa as well 
as the Sub-Saharan district.     
As per the World Health Organisation, the classification of premature and underweight 
infants is as follows[5]: 
• <28 weeks (w): extremely preterm 
• 28 to <32 weeks: very preterm 
• 32 to <37 weeks: moderate to late preterm  
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• <1000 grams (g): extremely low birth weight (ELBW) 
• 1000 g to <1500 g: very low birth weight (VLBW) 
• 1500 g to <2500 g: low birth weight (LBW). 
Objectives 
The objectives of this literature review were: 
1. To describe the impact of prematurity on paediatric morbidity, in terms of 
rehospitalisations and mortality in the research setting globally 
2. To describe the most common illnesses that require rehospitalisations in this 
population 
3. To review data on the risk factors associated with rehospitalisations and mortality in 
premature infants 
4. To review data on the protective factors associated with decreased rehospitalisation 
and mortality in premature infants 
5. To review available data related to rehospitalisation requiring admission to an 
intensive care unit (ICU), and any information regarding diagnosis, length of stay and 
requirement of mechanical ventilation 
Literature Search Strategy and Search Results 
Pubmed searches were made from inception until February 2018 using the following 
keywords 
1. Premature birth AND Patient readmission 
2. Infant, premature AND Patient readmission  
A total of 102 articles were found using the above search strategies, 13 of these studies were 
identified in more than both searches.  
The search was not limited in any way. Certain additional articles recommended by the 
supervisor or experts in the field were included in the review.  A total of 106 articles were 
reviewed, of which 26 articles are referenced in this literature review. The majority of the 
articles were published during or after 2010, but 10 articles from before this period were 
included.  
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6.1 Rehospitalisation Rate  
Several studies have been done over the years looking at the rehospitalisation rate to any 
ward after discharge from the birth admission (Table 1). Most of these studies have been 
done in the first world setting. Interestingly, despite the increased resources available in these 
countries, the rehospitalisation rate remains high.  
In 2003, a review focused on ELBW infants was published and specifically considered 
rehospitalisation rates by 2 years corrected age through different time periods[6]. It showed 
that despite medical advances, these rates were found to increase; in 1980-82%, 52% of the 
infants required rehospitalisation at least once, in 1991-1992, 62% and in 1997, 66%.  
Several studies have addressed rehospitalisation rates over various periods of time and most 
showed the majority of the rehospitalisations occur in the first year of life, even as high as 
49% of infants born before 32 weeks gestational age (GA) in Finland[7]. In Austria, a study 
found that 40% of infants born before 32 weeks GA required rehospitalisation, and almost 
half of these infants required multiple admissions within the first year[8].  
Two studies were done where children were followed up for 18 years and both found that 
premature infants required more rehospitalisations than term infants. In Australia, extremely 
preterm infants required an average of 6 admissions over 18 years, compared with <2 
admissions for term infants[9]. 62% of VLBW infants required rehospitalisation when followed 
up until the age of 18 years in Israel[10].  
A study done in India looked specifically at ELBW infants until the age of two corrected 
years[11]. The focus of this study was growth, and rehospitalisations over this period was a 
secondary outcome. 44% of these infants required rehospitalisations within the first year of 
life. This is in keeping with studies done in higher income settings[7,8].  
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Table 1 Rehospitalisation Rate 
Study Setting and 
participants 
Study Type Outcomes Findings 
Elder et al.[12] 
N=538 
1999 
GA <33 w at 
birth. Australia 
Prospective 
cohort study 
Rehospitalisations for 
the first year of life 
corrected age 
0.01%: died 
42%: one or more 
readmissions 
 
Escobar et al.[13] 
N=6054 
1999 
 
All neonates 
discharged 
from a 
neonatal 
intensive care 
unit (NICU). 
United States 
of America 
(USA) 
Retrospective 
cohort study 
Rehospitalisations in 
the first two weeks 
after discharge 
2.72%  
Doyle et al.[6] 
N=196 
2003 
 
ELBW infants 
randomly 
selected.  
First world 
countries 
Review article Comparison of 
rehospitalisation rate 
over three distinct 
time periods (1980-
1982, 1991-1992, 
1997) at 2 years 
corrected age 
1980-1982: 52% 
1991-1992: 62% 
1997: 66% 
Smith et al.[14] 
N=1597, 238 with 
bronchopulmonary 
dysplasia (BPD) 
2004 
GA <33 w, 
infants with 
BPD compared 
to those 
without. 
USA 
Retrospective 
cohort study 
Rehospitalisations in 
the first year of life 
BPD: 49% 
No BPD:23% 
Brissaud et al.[15] 
2005 
GA ≤ 33 w, 
discharged 
from neonatal 
unit.  
France 
Retrospective 
cohort study 
Rehospitalisations in 
the first year of life in 
1997 and 2002 
1997: 29.1% 
2002: 30.1% 
Escobar et al.[16] 
n=677 
2006 
GA 30-<35 w 
discharged 
from a 
neonatal unit. 
USA 
Retrospective 
cohort study 
Rehospitalisations 
within 3 months of 
discharge 
11.3% 
Tomashek et al.[17]. 
N=25324 
2006 
Live-born 
singleton 
infants, 
vaginally 
delivered, 
hospital stay <2 
nights 
USA 
Retrospective 
cohort study 
Rehospitalisation rate 
and diagnosis over 
first 28 days of life 
Late preterm: 3.5% 
Term: 2% 
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Underwood et al.[18] 
2007 
GA <36 w 
USA 
Prospective 
cohort study 
Rehospitalisation rate, 
diagnosis, length of 
stay over first year of 
life 
15% within first 
year of life 
Korvenranta et al.[7] 
n=2148 
2009 
GA <32 w, Birth 
weight (BW) 
<1501 g 
Finland 
Retrospective 
cohort study  
Prevalence of 
prematurity-related 
disorders and 
rehospitalisations over 
the first 3 years of life 
1st year: 49.3% 
2nd year: 28% 
3rd year: 20.9% 
Luu et al.[19] 
n=254 
2010 
GA ≤28/40 w 
Canada 
Prospective 
cohort study 
Neurodevelopmental 
outcomes and health 
care use until 18 
months corrected age 
23-25 w GA: 57% 
26-28 w GA: 49% 
Tseng et al.[20]. 
N=18421 
2010 
Any preterm 
GA, any LBW 
infant 
Taiwan 
Prospective 
cohort study 
Rehospitalisation 
within 31 days from 
discharge 
13.5% 
Ambalavanan et 
al.[21] 
N=3787 
2011 
BW <1000 g 
USA 
Retrospective 
analysis 
Rehospitalisation 
before 18-22 month 
corrected age  
Rehospitalisation for 
respiratory causes 
before 1 year 
chronological age 
Before 18-22 
months corrected 
age: 45% 
Before 1 year 
chronological age: 
14.7% 
Seki et al.[22] 
n=609 
2011 
GA <34 w 
Japan 
Prospective 
cohort study  
Rehospitalisation by 3 
months and by 1 year 
GA 22-25 w 
3 months: 10.4% 
1 year: 26.9% 
GA 26-34 w 
3 months: 2.8% 
1 year: 7.4% 
Ralser et al.[8] 
N=377 
2012 
GA <32 w 
Austria 
Prospective 
cohort study 
Rehospitalisations 
within first 2 years of 
life 
1st year: 40.1% 
2nd year: 24.7% 
Kuzniewicz et al. [23] 
2013 
GA >31 w 
USA 
Review article Rehospitalisations and 
emergency 
department visits in 
first 30 days after 
discharge 
31-33 w: 2.9% 
34-36 w: 8% 
37-38 w: 6.8% 
39 w +: 3.3% 
Vrijlandt et al.[24] 
n=2112 
GA <32 w 
compared to 
GA 32-36 w 
and GA ≥37 w 
The 
Netherlands 
Prospective 
cohort study 
Rehospitalisations for 
respiratory problems 
and respiratory 
symptoms until the 
age of 5 years 
<32 w: 17% 
32-36 w: 6% 
≥ 37 w: 3% 
Moyer et al.[25] 
n=1861 
2014 
GA 34-36 w 
USA 
Prospective 
cohort study 
Rehospitalisations 
within 28 days of birth 
3.6% 
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Mukhopadhyay et 
al.[11] 
n=79 
2014 
ELBW <1000 g 
India 
Prospective 
cohort study 
Followed up until 
corrected age of 2 
years 
Primary: proportion of 
underweight  
Secondary: proportion 
of stunting, 
microcephaly, 
wasting, mortality and 
morbidity during first 
year of age 
Rehospitalisation in 
first year: 44% (35 
of 79) 
21 children once, 9 
twice, 5 three 
times 
Deaths: 11% (9 of 
79) 
  
Slimings et al.[9] 
N= 721702 
2014 
All births 
Australia 
Retrospective 
cohort study 
Rehospitalisations 
until 18 years of age 
after birth discharge 
First 28 days: 4.4% 
Moderate and late 
preterm: 8.9% each 
of above 
After the neonatal 
period, extremely 
preterm infants 
had the highest 
rate of 
readmissions until 
the age of 18; 
>50% in the first 
year and >60% in 
from the second to 
fifth years of life.  
Over 18 years 
Extremely preterm: 
6 admissions 
Term: <2 
admissions 
 
Lee et al.[26] 
N=2351 
2015 
GA <33 w 
Korea 
Retrospective 
cohort study 
Followed up for an 
average of 425 days 
Outpatient, clinic, 
emergency 
department visits and 
hospitalisations 
33.6% 
Of 1322 
rehospitalisation 
events, 113 (8.5%) 
required 
mechanical 
ventilation 
14 infants died 
(0.6%), 11 of which 
occurred in the first 
year 
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Hong et al.[27] 
N=3322 
2016 
GA <32 w at 
birth.  
Australia 
Retrospective 
cohort study 
Rehospitalisations in 
the three years 
following discharge 
for respiratory causes 
and respiratory 
syncytial virus (RSV) -
related 
rehospitalisations 
0.91%: died 
63%: at least one 
rehospitalisation 
37.7%: respiratory 
rehospitalisation 
11.8%: RSV-related 
rehospitalisation 
Most of these 
deaths and 
readmissions 
occurred within the 
first year post 
discharge. 
Taylor et al.[28] 
N=142 
2016 
GA <29 w 
USA 
Retrospective 
cohort study 
Rehospitalisations 
within first two years 
of life 
Rehospitalisations 
At 1 year: 42% 
(18% multiple 
rehospitalisations) 
At 2 years: 45%  
7 died (0.05%)  
Kuint et al.[10] 
N=6385 
2017 
VLBW 1500 g 
Israel 
Observational 
study 
Rehospitalisations 
within 18 years from 
birth discharge 
62%  
 
6.2 Diagnosis at Rehospitalisation 
There have been many studies that address the common reasons that premature infants 
require rehospitalisation (Table 2). Most seem to indicate that respiratory disorders and 
infections are the commonest cause of rehospitalisations in premature infants. 
Jaundice, infection and feeding issues were often the reason for rehospitalisations within the 
first month of life[13,17,23]. But infants followed up for a longer time were noted to have very 
different reasons for rehospitalisation.  
Various studies done from 1999[12] to 2016[28] found respiratory illnesses to be the 
commonest reason for diagnosis. In 2010, researchers in Canada[19] found that 63% of their 
infants born before 28 w GA required admission for respiratory illnesses when followed up 
until 18 months corrected age.  
Doyle et al.[6] reviewed several studies specifically considering ELBW infants in the first world 
setting. As mentioned previously, this studied focused on rehospitalisations until two years 
corrected age over three separate time periods: 1980-1982, 1991-1992, and 1997. 
Throughout all three time periods, medical reasons for rehospitalisations were found to be 
  Page 15 of 76 
more common, in particular respiratory rehospitalisations. Infection with RSV was also found 
to be a common cause of respiratory illness requiring rehospitalisation[18,27].  
In India, ELBW infants were followed up until two years corrected age. This is the only study 
done in a low-income setting[11]. Infections were found to be the reason for rehospitalisation 
in the majority of cases (15% sepsis, 15% pneumonia, 11% acute gastroenteritis, 6% 
bronchiolitis). There was a high rate of loss to follow-up during the study and this may have 
resulted in an underestimate of mortality and rehospitalisations.   
Surgical admissions for repair of inguinal hernias were also one of the more common reasons 
for rehospitalisation[12,14]. 
Table 2 Diagnosis at Rehospitalisation 
Study Setting and 
participants 
Study Type Outcomes Findings 
Elder et al.[12] 
n=538 
1999 
GA <33 w at 
birth. 
Australia 
Prospective 
cohort study 
Rehospitalisations 
for the first year of 
life corrected age 
83.5% of 
rehospitalisations: 
medical, almost half of 
these acute respiratory 
illnesses 
16.5% of 
rehospitalisations: 
surgical, majority for 
repair of inguinal hernia 
Escobar et. 
al[13]. 
n=6054 
1999 
 
All neonates 
discharged 
from a NICU. 
USA 
Retrospective 
cohort study 
Rehospitalisations in 
the first two weeks 
after discharge 
Jaundice and feeding 
issues 
Doyle et al.[6] 
n=196 
2003 
 
ELBW infants 
randomly 
selected.  
First world 
countries 
Review 
article 
Comparison of 
rehospitalisation rate 
over three distinct 
time periods (1980-
1982, 1991-1992, 
1997) at 2 years 
corrected age 
Medical admissions more 
common, particularly 
respiratory 
rehospitalisations 
Smith et al.[14] 
n=1597, 238 
with BPD 
2004 
GA <33 w, 
infants with 
BPD 
compared to 
those without. 
USA 
Retrospective 
cohort study 
Rehospitalisations in 
the first year of life 
Respiratory diagnoses 
and hernia repair 
Brissaud et 
al.[15] 
2005 
GA ≤ 33 w, 
discharged 
Retrospective 
cohort study 
Rehospitalisations in 
the first year of life 
in 1997 and 2002 
Respiratory disease 
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from neonatal 
unit.  
France 
Tomashek et 
al.[17] 
n=25324 
2006 
Live-born 
singleton 
infants, 
vaginally 
delivered, 
hospital stay 
<2 nights 
USA 
Retrospective 
cohort study 
Rehospitalisation 
rate and diagnosis 
over first 28 days of 
life 
Jaundice and infection 
Jain et al.[29] 
n=279 
2006 
GA 34-36 w 
presenting to 
emergency 
department 
USA 
Observational 
study 
Admission diagnosis 
and rehospitalisation 
over first 31 days of 
life 
The six most common 
diagnosis accounted for 
70% of the admissions. 
Gastrointestinal (20.4%), 
respiratory (15.8%), 
jaundice (12.2%), 
infectious (8.2%), feeding 
problem (7.5%), fever 
6.8%) 
Underwood et 
al.[18] 
2007 
GA <36 w 
USA 
Prospective 
cohort study 
Rehospitalisation 
rate, diagnosis, 
length of stay in the 
first year of life 
Acute respiratory 
diseases most frequent, 
RSV most common 
pathogen 
Luu et al.[19] 
n=254 
2010 
GA ≤28/40 w 
Canada 
Prospective 
cohort study 
Neurodevelopmental 
outcomes and health 
care use until 18 
months corrected 
age 
63%: respiratory illness, 
16% surgery, 11% 
gastrointestinal/nutrition 
problems 
Ambalavanan 
et al.[21] 
n=3787 
2011 
BW <1000 g 
USA 
Retrospective 
analysis 
Rehospitalisation 
before 18-22 month 
corrected age 
Rehospitalisation for 
respiratory causes 
before 1 year 
chronological age 
45.4%: respiratory 
diagnosis 
20.5%: surgery 
6% infection 
Ralser et al.[8] 
n=377 
2012 
GA <32 w 
Austria 
Prospective 
cohort study 
Rehospitalisations 
within first 2 years of 
life 
Respiratory disorders 
most common 
Kuzniewicz et 
al. [23] 
2013 
GA >31 w 
USA 
Review 
article 
Rehospitalisations 
and emergency 
department visits in 
first 30 days after 
discharge 
31-33 w: Infection, 
respiratory disorders 
34 w +: Infection, 
jaundice 
Mukhopadhyay 
et al.[11] 
n=79 
2014 
ELBW <1000 g 
India 
Prospective 
cohort study 
Followed up until 
corrected age of 2 
years 
Primary: proportion 
of underweight  
Secondary: 
proportion of 
Anaemia 19% 
Sepsis 15% 
Pneumonia 15% 
Acute gastroenteritis 
11% 
Bronchiolitis 6% 
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stunting, 
microcephaly, 
wasting, mortality 
and morbidity during 
first year of age 
Laser treatment of 
retinopathy of 
prematurity 6% 
Inguinal hernia 12% 
Fever 6% 
 
Deaths: 9 children (11%) 
Sepsis 6, pneumonia 3  
Lee et al.[26] 
n=2351 
2015 
GA <33 w 
Korea 
Retrospective 
cohort study 
Followed up for an 
average of 425 days 
Outpatient, clinic, 
emergency 
department visits 
and hospitalisations 
18.4% respiratory 
problems 
Hong et al.[27] 
n=3322 
2016 
GA <32 w at 
birth. 
Australia  
Retrospective 
cohort study 
Rehospitalisations in 
the three years 
following discharge 
for respiratory 
causes and RSV-
related 
rehospitalisations 
37.7%: respiratory 
rehospitalisation 
11.8%: RSV-related 
rehospitalisation 
 
6.3 Risk Factors for Rehospitalisation 
It is vitally important to identify factors that increase the likelihood of premature infants 
requiring rehospitalisations. This could potentially have a significant impact on the follow-up 
required for infants identified as high risk.  
Many studies have been done to try to accurately determine these risk factors (Table 3). Male 
sex[8,12,14,16,20,27] was consistently found to be associated with an increased rate of 
rehospitalisations. 
Lower gestational age at birth and lower birth weight[14,15,18,20] were both frequently found to 
result in a higher frequency of rehospitalisations. A birth weight below 1000 g was specifically 
noted to be associated with increased rates of rehospitalisations[15,20].  
Chronic lung disease (CLD) and bronchopulmonary dysplasia also leads to increased 
frequency of rehospitalisations[8,12,15].  
Kuint et al.[10] followed VLBW infants for 18 years of life and assessed whether having certain 
morbidities were associated with an increased requirement for rehospitalisations. They 
specifically looked at the following morbidities: necrotising enterocolitis (NEC), necrotising 
enterocolitis with surgery, intraventricular haemorrhage (IVH) grades 3-4, periventricular 
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leukomalacia, bronchopulmonary dysplasia and retinopathy of prematurity stages 3-4. They 
found that those with necrotising enterocolitis requiring surgery and grades 3-4 IVH were at 
highest risk. Of note, they found that the presence of one of these morbidities increased the 
risk of rehospitalisation by 2.7-fold, the presence of two morbidities by 2.46-fold, and three 
or more by 4.22-fold excess risk. The presence of morbidities could potentially have a 
significant effect on the needs for rehospitalisations in an already susceptible group of 
patients. 
Table 3 Risk Factors for Rehospitalisation 
Study Setting and 
participants 
Study type Outcomes Findings 
Elder et 
al.[12] 
n=538 
1999 
GA <33 w at 
birth. 
Australia 
Prospective 
cohort study 
Rehospitalisations for 
the first year of life 
corrected age 
Medical 
rehospitalisations: 
aboriginal race, male sex 
and CLD 
Surgical 
rehospitalisations: male 
sex, lower GA, severe 
HMD, severe CLD, 
birthweight <10th centile 
Escobar et. 
al[13]. 
n=6054 
1999 
 
All neonates 
discharged 
from a NICU.  
USA 
Retrospective 
cohort study 
Rehospitalisations in 
the first two weeks 
after discharge 
Highest rate of 
rehospitalisation in 
those with GA 33 to 36 w 
Smith et 
al.[14] 
n=1597, 238 
with BPD 
2004 
GA <33 w, 
infants with 
BPD 
compared to 
those 
without. 
USA 
Retrospective 
cohort study 
Rehospitalisations in 
the first year of life 
No BPD: Lower GA, 
lower BW, male sex, 
longer initial NICU 
hospitalisation, longer 
duration of respiratory 
support, presence of 
NEC and IVH 
Brissaud et 
al.[15] 
2005 
GA ≤ 33 w, 
discharged 
from 
neonatal 
unit.  
France 
Retrospective 
cohort study 
Rehospitalisations in 
the first year of life in 
1997 and 2002 
BW <1000 g, CLD, GA 
<28 w 
Escobar et 
al.[16] 
n=677 
2006 
GA 30-<35 w 
discharged 
from a 
neonatal unit 
USA 
Retrospective 
cohort study 
Rehospitalisations 
within 3 months of 
discharge 
Male sex 
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Underwood 
et al.[18] 
2007 
GA <36 w 
USA 
Prospective 
cohort study 
Rehospitalisation 
rate, diagnosis, length 
of stay over first year 
of life 
GA <25 w  
BW <1000 g 
Luu et al.[19] 
n=254 
2010 
GA ≤28/40 w 
Canada 
Prospective 
cohort study 
Neurodevelopmental 
outcomes and health 
care use until 18 
months corrected age 
BPD, severe brain injury, 
use of home oxygen or 
apnoea monitor, older 
chronological age at 
neonatal discharge.  
Tseng et 
al.[20] 
N=18421 
2010 
Any preterm 
GA, any LBW 
infant 
Taiwan 
Prospective 
cohort study 
Rehospitalisation 
within 31 days from 
discharge 
Male, BW <1000g, 
congenital 
abnormalities, lung 
disease 
Ralser et 
al.[8] 
n=377 
2012 
GA <32 w 
Austria 
Prospective 
cohort study 
Rehospitalisations 
within first 2 years of 
life 
1st year: CLD, male sex, 
smoking in pregnancy 
2nd year: CLD 
Lee et al.[26] 
n=2351 
2015 
GA <33 w 
Korea 
Retrospective 
cohort study 
Followed up for an 
average of 425 days 
Outpatient, clinic, 
emergency 
department visits and 
hospitalisations 
GA <30 w  
Hong et 
al.[27] 
n=3322 
2016 
GA <32 w at 
birth 
Australia 
Retrospective 
cohort study 
Rehospitalisations in 
the three years 
following discharge 
for respiratory causes 
and RSV-related 
rehospitalisations 
High respiratory 
rehospitalisations: male 
gender, requiring 
intubation resuscitation 
at birth, culture-proven 
systemic infection, 
maternal indigenous 
status, major congenital 
anomalies, higher days 
of assisted ventilation, 
severe BPD requiring 
home oxygen 
RSV  
High RSV-related 
rehospitalisations: Lower 
gestational age at birth, 
severe BPD requiring 
home oxygen, 
indigenous background, 
assisted ventilation 
Taylor et 
al.[28] 
n=142 
2016 
GA <29 w 
USA 
Retrospective 
cohort study 
Rehospitalisations 
within first two years 
of life 
Rehospitalisations: 
number of respiratory 
infections, inhaled 
steroid use at 1 year 
PICU Rehospitalisations: 
pulmonary hypertension 
in NICU, prolonged 
oxygen use, increasing 
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6.4 Protective Factors that Reduce Rehospitalisations  
Five studies specifically noted factors that reduced the likelihood of rehospitalisations (Table 
4). Two of the studies looked closely at rehospitalisations within the first few months of life.  
In Taiwan[20], all infants who were identified as either premature or any low birth weight were 
followed up prospectively for the first 31 days post discharge. A neonatal length of stay less 
than 35 days was seen as a protective factor. This may be a marker for less morbidity within 
the neonatal period leading to a shorter hospital stay at birth.  
On the other hand, preterm infants born between 34 to 36 weeks GA (moderate preterm) in 
USA required fewer rehospitalisations if they were born via caesarean section or if they had 
a longer neonatal length of stay[25]. This may point to a concern that although moderate 
preterm infants are often not as unwell at birth, they may still have significant morbidity 
associated with prematurity. A longer initial hospital stay to identify these morbidities and 
adequately manage them may reduce their risk for rehospitalisations. Three of these studies 
followed the infants for one year or longer.  
In Australia[27], 3322 infants born before 32 weeks were noted to have fewer 
rehospitalisations over the first three years of life if they received exogenous surfactant in the 
birth hospitalisation.  
number of respiratory 
infections 
Multiple 
rehospitalisations: 
increasing number of 
respiratory infections 
and feeding problems 
Kuint et 
al.[10] 
n=6385 
2017 
VLBW 1500 
g 
Israel 
Observational 
study 
Rehospitalisations 
within 18 years from 
birth discharge 
Younger maternal age at 
delivery, maternal 
ethnicity, lower GA, 
multiple birth, male sex, 
small for gestational age, 
delivery room 
resuscitation, congenital 
malformations 
VLBW with any major 
morbidity, particularly 
NEC requiring surgery 
and grades 3-4 IVH  
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Interestingly, two of these studies identified breast milk ingestion as protective factors. In 
1999, Elder et al.[12] found this in Australia in infants born before 33 weeks GA. Interestingly, 
17 years later, in USA, Taylor et al.[28] found the same in premature infants born before 29 
weeks GA. This is valuable information as encouraging breast milk feeds, sometimes via 
expressed milk, is an inexpensive and safe intervention that should probably be a priority in 
all neonatal units globally.  
Table 4 Protective Factors that Reduce Rehospitalisations 
Study Setting and 
participants 
Study type Outcomes Findings 
Elder et 
al.[12] 
n=538 
1999 
GA <33 w at 
birth. 
Australia 
Prospective 
cohort study 
Rehospitalisations 
for the first year of 
life corrected age 
Medical readmission: 
Breastfeeding 
 
Tseng et 
al.[20] 
N=18421 
2010 
Any preterm 
GA, any LBW 
infant 
Taiwan 
Prospective 
cohort study 
Rehospitalisation 
within 31 days from 
discharge 
Shorter neonatal length of 
hospital stay (<35 days) 
Moyer et 
al.[25] 
n=1861 
2014 
GA 34-36 w 
USA 
Prospective 
cohort study 
Rehospitalisations 
within 28 days of 
birth 
Delivery via caesarean 
section with longer initial 
hospital stay 
Hong et 
al.[27] 
n=3322 
2016 
GA <32 w at 
birth. 
Australia  
Retrospective 
cohort study 
Rehospitalisations 
in the three years 
following discharge 
for respiratory 
causes and RSV-
related 
rehospitalisations 
Respiratory 
hospitalisations: 
exogenous surfactant 
administration  
RSV-related 
rehospitalisations: older 
maternal age at birth 
Taylor et 
al.[28] 
n=142 
2016 
GA <29 w 
USA 
Retrospective 
cohort study 
Rehospitalisations 
within first two 
years of life 
Breastmilk ingestion 
 
6.5 PICU Rehospitalisation 
In 2010, Gunville et al.[30] reviewed PICU hospitalisations for acute respiratory illness in all 
children under the age of two years at a tertiary centre in Denver, Colorado (Table 5). There 
were 271 infants included in the study and 30% of these children were preterm; 17% early 
preterm (<32 w GA) and 12% late preterm (32 - <36 w GA). The most common diagnosis 
among all these children was lower respiratory tract infection.  
  Page 22 of 76 
They found that preterm infants had a longer length of stay in the PICU and used more 
hospital resources during their hospitalisation.   
In a prospective study in 16 different centres in the USA, Mourani[31] et al. identified 512 
infants who were born 34 weeks, with a birth weight between 500 and 1250 g who required 
mechanical ventilation within the first 48 hours of life (Table 5). These infants had been 
recruited for another randomised controlled trial and were followed up until the age of four 
and a half years. 18.7% (96 of 512) of these children required rehospitalisation to a paediatric 
ICU, and most of these were in the first year of life (75 of 96). The average length of stay in 
the PICU was 13.6% days per rehospitalisation. Three of these 96 children demised.  
47 of the 96 children who were admitted a PICU required mechanical ventilation for an 
average of 11.6 days. There was an increased risk for rehospitalisation into a PICU in male 
infants and those with intracranial haemorrhage at discharge from the birth hospitalisation.  
Two years later, Taylor et al.[28] found that 10% of infants born before 29 weeks GA were 
rehospitalised to a PICU within the first two years of life (Table 5). The average age of 
admission was at the age of 13 months. Some identified risk factors were the use of inhaled 
steroids, diuretics or diuretics at the age of one year.  
Table 5 PICU Rehospitalisation 
Study Setting and 
participants 
Study type Outcomes Findings 
Gunville 
et al.[30] 
n=271 
2010 
Children 
admitted to 
PICU less than 
2 years of age 
with acute 
respiratory 
illness 
USA 
Retrospective 
cohort study 
Diagnosis, length of 
stay, hospital 
charges 
Most common diagnosis: 
lower respiratory tract 
infection.  
Preterm infants: longer PICU 
length of stay, utilised more 
hospital resources, incurred 
higher hospital charges 
compared with term infants.  
 
Mourani 
et al.[31] 
n=512 
2014 
GA ≤34 w 
BW 500-1250 
g 
<48h old 
Required 
mechanical 
ventilation 
USA 
Prospective 
cohort study 
of patients 
who had been 
involved in a 
randomised 
controlled trial 
at birth using 
inhaled nitric 
Hospital 
readmissions and 
outpatient 
resource use until 
4.5 years age   
Rehospitalisations: 57.8% 
(296) of total 
 
ICU rehospitalisations: 
18.7% (96 of 512) of total- 
75 of these in the first year 
of life. Average of 13.6 days 
ICU days per admission 
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oxide vs a 
placebo  
Mechanical ventilation 
during rehospitalisations: 
9.1%, (47 of 512)  
Average of 11.6 days on 
mechanical ventilation 
3 deaths 
 
Male sex and the presence 
of intracranial haemorrhage 
at discharge from birth 
hospitalisations were risk 
factors associated with ICU 
rehospitalisation 
Taylor et 
al.[28] 
n=142 
2016 
GA <29 w 
USA 
Retrospective 
cohort study 
Rehospitalisations 
within first two 
years of life 
10% ICU rehospitalisations, 
average age: 13 months 
 
Risk factors: pulmonary 
hypertension in NICU 
prolonged oxygen use, 
increasing number of 
respiratory infections.  
The use of diuretics/inhaled 
steroids/oxygen at 1 year  
  
 
Summary 
Many studies have been done focused on readmissions in premature infants, most of these 
in the first world setting. Various studies done from the 1990s[6] until 2017[10] have shown 
that premature infants have a high rate of rehospitalisation after discharge. The highest 
frequency of rehospitalisations were generally in the first year of life, as high as 49% in infants 
born before 32 weeks GA in Finland[7].  In India, 44% of ELBW infants required 
rehospitalisations within the first year of life[11]. The increased rate of rehospitalisations 
persists until 18 years. In Australia, extremely preterm infants required an average of 6 
admissions (term infants <2 admissions)[9] and in Israel, 62% of VLBW infants required 
rehospitalisation[10].  
Within the first month of life, jaundice, infection and feeding issues were often the reason for 
rehospitalisations [13,17,23]. But as premature infants grow up, respiratory illnesses are the 
commonest reason for readmission [6,12,19,28]. Infection with respiratory syncytial virus was 
often associated with respiratory illness requiring rehospitalisation[18,27]. In India, infections 
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(sepsis, pneumonia and acute gastroenteritis) lead to rehospitalisation in the majority of 
cases in ELBW infants in the first year of life [11].  
Male sex[8,12,14,16,20,27],  CLD/BPD[8,12,15], lower gestational age at birth and lower birth 
weight[14,15,18,20] increased the risk of rehospitalisations, particularly a birth weight below 1000 
g[15,20]. Kuint et al.[10]  found that the presence of any morbidity associated with prematurity 
increased the rate of rehospitalisation in VLBW infants until 18 years of age in Israel.  
Interestingly, two studies identified breast milk ingestion as protective factors to decrease 
the risk of rehospitalisations[12,28]. Despite medical advances, breast milk remains a critical 
target for reducing morbidity in premature infants.  
Acute respiratory illnesses have consistently been found to be the most common reason for 
readmission into ICU, in particular, lower respiratory tract infection[30]. In 16 centres in 
USA[31], premature infants had a high rate of rehospitalisations (18.7%) and required 
prolonged ICU stays with an average of 13.6 days per admission. Most of these admissions 
were in the first year of life.   
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7.2 Abstract 
Background: Prematurity is a major risk factor for morbidity and mortality in children. 
Rehospitalisation with paediatric intensive care unit (PICU) admission constitutes significant 
morbidity. There is a paucity of literature regarding rehospitalisations of premature infants in 
South Africa.  
Objective: To describe the outcomes, clinical course and characteristics of premature infants 
admitted to a South African PICU, and to identify any predictors of mortality.  
Methods: This prospective observational study analysed unplanned PICU admissions of 
premature and ex-premature infants in the first six months of life, over a six-month period. 
The primary and secondary outcomes were mortality and length of PICU stay, respectively. 
Data were analysed using standard descriptive and inferential statistics. 
Results: 29 infants (65% male; median (IQR) birth weight (BW) and gestational age (GA) 1715 
(1130 - 2340) g and 32 (29 - 34) weeks respectively) in 33 admissions were included. Five 
(17.2%) infants died in PICU.  
Apnoea (39.4%), respiratory failure (24.2%) and shock (24.2%) were the commonest reasons 
for PICU admission, secondary to pneumonia (33.3%), sepsis (27.3%) and meningitis (12.1%). 
72.4% of infants were mechanically ventilated and 48.3% received blood transfusions. 
Higher revised Paediatric Risk of Mortality (PIM2) score (p = 0.03), inotrope use (p < 0.0001), 
longer duration of mechanical ventilation (p = 0.03), and cardiac arrest in PICU (p < 0.0001) 
were associated with mortality on univariate analysis with no independent predictors of 
mortality.  
Conclusion: Infections leading to apnoea, respiratory failure and shock are common 
indications for PICU readmission in premature infants. Mechanical ventilation and blood 
transfusion were frequently required.  
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7.3 Introduction 
Prematurity is a major risk factor for morbidity and mortality. According to the World Health 
Organisation (WHO), preterm birth complications are the leading cause of death in children 
under-5 years[1]. In the Metro west geographical service area of the Western Cape Province, 
South Africa, prematurity was reported to be the third leading cause of death; accounting for 
9.3% of all under-five deaths in the region[2]. There have been dramatic advancements in the 
knowledge and care of premature infants, with associated improvements in survival, even in 
cases which would previously have been considered futile. These interventions include the 
use of incubators, surfactant and continuous positive airway pressure[3]. However, these 
premature infants may survive  with  significant morbidity[4], and associated increased 
demands on the health care system and family in the future. 
Studies conducted in well-resourced countries have identified premature infants as being at 
high risk of requiring readmission to hospital[5,6], with those readmitted to the neonatal or 
paediatric intensive care unit (PICU) being at increased risk of poor clinical outcome 
(prolonged PICU stay and mortality) compared to the general PICU population[7]. Male sex [5,8-
12], chronic lung disease/bronchopulmonary dysplasia [8,11,13], lower gestational age (GA) at 
birth and lower birth weight (BW)[5,9,13,14] have been reported to be associated with increased 
risk of rehospitalisations, particularly a birth weight below 1000 grams (g)[5,13]. Kuint et al.[15]  
found that the presence of any morbidity associated with prematurity increased the rate of 
rehospitalisation in very low birth weight infants (VLBW) until 18 years of age in Israel. 
Breastfeeding has been identified as a protective factor[8,16] reducing the likelihood of 
rehospitalisation.  
Acute respiratory illnesses, particularly lower respiratory tract infections, have consistently 
been reported to be a common reason for readmission into ICU[17]. Across 16 centres in the 
United States of America[7], premature infants had a high rate of rehospitalisations (18.7%) 
and required prolonged ICU stays with an average of 13.6 days per admission. Most of these 
admissions were in the first year of life. There is limited data on the characteristics, outcomes 
and impact on the healthcare system of infants requiring readmission to PICU in low and 
  Page 31 of 76 
 
middle-income countries. A study done in India found that infections (sepsis, pneumonia and 
acute gastroenteritis) lead to rehospitalisation in the majority of cases in extremely low birth 
weight (ELBW) infants in the first year of life[18]. Forty four percent of their cohort of ELBW 
infants were rehospitalised and 11% of these died within the first year of life.  It is particularly 
important to identify infants at increased risk of poor clinical outcomes in resource-
constrained environments as they may require closer surveillance and support. This study 
aims to describe the incidence, demographics, clinical course and outcomes of premature 
infants admitted to a South African PICU, following initial hospital discharge, within the first 
six months of life. Currently there are no published studies reflecting data from South Africa 
or the broader Sub-Saharan region.     
7.4 Methods 
Study design and participants 
This was a prospective observational study of all premature infants below the age of six 
months, admitted to the PICU at Red Cross War Memorial Children’s Hospital (RCWMCH), 
Cape Town, South Africa, from 1 May 2016 to 31 October 2016. All planned admissions, such 
as those admitted following elective surgery, were excluded from the study. The Human 
Research Ethics Committee (HREC) at University of Cape Town granted ethical approval for 
this study (approval no. HREC REF: 103/2016) and informed consent was taken from 
participants’ parents or legal guardians.  
Setting 
RCWMCH is the only paediatric tertiary level (L3) hospital within the Cape Town Metro West 
geographical service area in Western Cape, with a wide scope of subspecialty services offered. 
The PICU at RCWMCH is a 22-bed unit providing the only intensive care unit (ICU) for 
paediatric admissions within the public health sector in the region. The neonatal services 
within this district are offered by one L3 hospital (Groote Schuur Hospital) several secondary 
level (L2) hospitals (New Somerset Hospital, Mowbray Maternity Hospital and George 
Hospital) and district level (L1) hospitals and multiple maternity obstetric units. Tygerberg 
Hospital offers tertiary level services to the Metro East geographical service area. Usually, 
once an infant is discharged from the neonatal services, any rehospitalisations required would 
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be to a paediatric unit, including RCWMCH. During the period of data collection, the staffing 
of the PICU in terms of the nurses and doctors remained fairly stable.  
Definitions 
As per the WHO[19], the classification of premature and underweight infants is as follows: 
• <28 weeks: extremely preterm 
• 28 to <32 weeks: very preterm 
• 32 to <37 weeks: moderate to late preterm  
• <1000 g: extremely low birth weight (ELBW) 
• 1000 g to <1500 g: very low birth weight (VLBW) 
• 1500 g to <2500 g: low birth weight (LBW). 
Gestational age of any infant is determined using several options which include antenatal 
ultrasonography, calculations based on last menstrual period and scoring based on physical 
examination of the neonate, such as the Ballard Score. A correlation between foot length and 
gestational age is possible but was not used during the period prior to data collection for this 
study. An early ultrasound done up to 23 completed weeks is considered to be the most 
accurate estimate of GA. Soon after birth, the GA of a child is determined by the attending 
clinician based on one or more of the above-mentioned assessments. 
Data collection  
Daily checks were made to identify patients who fulfilled inclusion criteria. Once informed 
consent was obtained from the parent or legal guardian, medical records and “Road to 
Health” books (RTHB) of each infant were reviewed.  
Birth weight, gestational age at birth, gender, mode of delivery, and date of birth was 
recorded for each participant. The corrected age and chronological age were then calculated 
for each child. The RTHB was reviewed to collect data regarding initial hospital length of stay 
following birth, morbidities, discharge weight, immunization status as well as human 
immunodeficiency virus (HIV) status.  
HIV status was classified as uninfected, exposed but uninfected, infected not on treatment, 
and infected on treatment. 
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Immunisation status was based on the expected immunisations that each child should have 
received at the time of admission based on the South African Extended Programme on 
Immunisation (EPI). 
The weight of the infant on the day of admission to PICU was used to assess the child’s growth 
since discharge from the neonatal unit. The nutritional status of each child was determined 
using weight-for-age (WAZ) and weight-for-height/ length (WHZ) z-scores after correction for 
prematurity, calculated using the “zanthro” function of Stata®/IC 13.0 statistical software. 
The WHO 2007 UK term and preterm growth charts were used for reference (Birth: British 
1990 Growth Reference, reanalysed 2009; Postnatal: WHO Child Growth Standards; 4-20 
years: British 1990 Growth Reference). A child was assessed as growing slowly if they had 
gained weight since the time of discharge from the neonatal unit but had not followed the 
trend according to the previously mentioned growth charts.  
During the PICU admission, data regarding initial reason for admission, revised Paediatric 
Index of Mortality (PIM2) score, diagnosis on discharge, mode of feeding (breastmilk, formula 
feeds or mixed feeding), length of stay, respiratory support, transfusion of blood and blood 
products and unexpected interventions such as surgery or dialysis was collected. Laboratory 
results related to haemoglobin (Hb), microbiological and viral studies were also collected. The 
PIM2 score is designed for use in any PICU and uses various physiologic variables to assist 
with mortality risk assessment at initial admission to PICU[20]. It is used as a benchmark to 
assess performance in any PICU and has been validated for use in the PICU at RCWMCH[21]. A 
standardised mortality rate (actual mortality over predicted mortality) below one is a good 
reflection as it shows that fewer patients die than those predicted using the PIM2 score.  
Data Analysis and Main Outcome Measures 
Data were tested for normality using the Shapiro Wilks W test. Descriptive data are presented 
as n (%) for categorical variables and either median (interquartile range, IQR) or mean 
(standard deviation (SD)) according to distribution for continuous variables. Inferential 
statistics were conducted using Chi-square tests (or yates corrected Chi- square as 
appropriate) for categorical variables and continuous data were compared using Mann-
Whitney U or t- tests for independent variables. The primary outcome measure was mortality 
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and secondary outcome was length of PICU stay. Data identified as being significantly 
associated with mortality on univariate analysis were entered into a backward stepwise 
binary logistic regression model to determine any independent predictors. A p-value < 0.05 
was considered significant for all tests. Statistica 13 (StatSoft Inc, USA) was used for statistical 
analysis. 
7.5 Results 
During the six-month study period there were 584 admissions to the PICU, of which 33 (5.7%) 
were unplanned admissions of 29 premature-born infants (males, n=19; 65.5%). Within the 
same period, there were a total of 43 deaths in PICU, five (11.6%) of whom were patients 
included in this study (Table 1).  
Patient characteristics and outcomes 
Characteristics and outcomes of the 29 included infants are presented in Table 1. One (3.4%) 
child had a GA of 24 weeks; 11 (37.9%) were very preterm and 17 (58.6%) were moderate to 
late preterm infants. The majority (51.7%) of infants had spent more than four weeks in the 
neonatal unit.  
Eight (27.6%) infants were discharged from the neonatal unit with a known morbidity, the 
commonest of these being a late infection (10.3%) during the birth hospitalisation. One of the 
infants had a grade 3-4 intraventricular haemorrhage, and another had necrotising 
enterocolitis during the neonatal admission. More than half of the infants (51.7%) admitted 
to the PICU had a neonatal length of stay exceeding four weeks.  
Of the 29 infants requiring readmission to PICU, nine (31%) were noted to have a WAZ or WHZ 
z-score below -2 at the time of readmission or had lost weight since discharge from the 
neonatal unit. These children were classified as malnourished (Table 1). Two of these children 
were on formula feeds. None of the children were HIV infected.  
Table 1: Admission Characteristics and Outcomes (n=29) 
 All Died Survived p value 
Male Gender 19 (65.5%) 4 (13.8%) 15 (51.7%) 0.5 
Delivery by 
caesarian section  
8 (27.6%) 1 (3.4%) 7 (24.1%) 0.7 
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BW median (IQR) (g) 1715 (1130 - 2340) 1800 (1180 - 
2410) 
1667.5 (1115 - 
2320) 
0.8 
GA median (IQR) 
(weeks) 
32 (29 - 34) 32 (28 – 34) 
 
32.5 (29 - 34) 0.9 
PIM2 Score median 
(IQR) (%) 
4.13 (1.36 - 7.56) 13.17 (7.56 - 
62.23) 
3.8 (1.08 - 
5.53) 
0.03 
Length of stay in neonatal unit 
None 4 (13.8%) 2 (6.9%) 2 (6.9%) 0.4 
<4 days 2 (6.9%) 0 2 (6.9%) 
4 - <7 days 2 (6.9%) 0 2 (6.9%) 
1 - 2 weeks 5 (17.2%) 1 (3.4%) 4 (13.8%) 
2 - 4 weeks 1 (3.4%) 0 1 (3.4%) 
>4 weeks 15 (51.7%) 2 (6.9%) 13 (44.8%) 
Presence of 
Morbidities 
8 (27.6%) 2 (6.9%) 6 (20.7%) 0.4 
Corrected Age on PICU admission 
35 - < 37 weeks 7 (24.1%) 1 (3.4%) 6 (20.7%) 0.8 
37 - < 40 weeks 7 (24.1%) 2 (6.9%) 5 (17.2%) 
40 weeks to <1 
month 
6 (20.7%) 1 (3.4%) 5 (17.2%) 
1 to <3 months 5 (17.2%) 1 (3.4%) 4 (13.8%) 
≥ 3 months 4 (13.8%) 0 4 (13.8%) 
Actual Age on PICU admission 
<1 month 8 (27.6%) 2 (6.9%) 6 (20.7%) 0.7 
1 - <2 months 7 (24.1%) 1 (3.4%) 6 (20.7%) 
2 - <4 months 10 (34.5%) 2 (6.9%) 8 (27.6%) 
4 - 6 months 4 (13.8%) 0 4 (13.8%) 
Admission weight 
<2 kg 6 (20.7%) 0 6 (20.7%) 0.4 
2 -< 4 kg 19 (65.5%) 5 (17.2%) 14 (48.3%) 
4 - <6 kg 3 (10.3%) 0 3 (10.3%) 
≥6 kg 1 (3.4%) 0 1 (3.4%) 
Growth since discharge 
Growing well 14 (48.3%) 3 (10.3%) 11 (37.9%) 0.5 
Growing slowly 6 (20.7%) 0 6 (20.7%) 
Malnourished or 
weight loss 
9 (31%)  2 (6.9%)  7 (24.1%) 
Time since Neonatal Unit discharge 
<1 weeks 2 (6.9%) 0 2 (6.9%) 0.1 
1 - 2 weeks 3 (10.3%) 0 3 (10.3%) 
>2 weeks - 1 month 8 (27.6%) 4 (13.8%)  4 (13.8%) 
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>1 - <2 months 10 (34.5%) 1 (3.4%) 9 (31%) 
≥2 months 6 (20.7%) 0 6 (20.7%) 
Immunisations not 
up to date 
11 (37.9%) 0 11 (37.9%) 0.1 
Feeding 
Breast 21 (72.4%) 4 (13.8%) 17 (58.6%) 0.7 
Formula 5 (17.2%) 1 (3.4%) 4 (13.8%) 
Mixed 3 (10.3%) 0 3 (10.3%) 
HIV Status 
HIV positive 0 0 0 0.3 
HIV exposed, but 
negative 
4 (13.8%) 0 4 (13.8%) 
HIV unexposed 25 (86.2%) 5 (17.2%) 20 (69%) 
ICU days 
<1 day 2 (6.9%) 0 2 (6.9%) 0.1 
1 day 3 (10.3%) 2 (6.9%) 1 (3.4%) 
2 - 3 days 8 (27.6%) 1 (3.4%) 7 (24.1%) 
4 - 7 days 8 (27.6%) 0 8 (27.6%) 
>7 days 8 (27.6%) 2 (6.9%) 6 (20.7%) 
Mechanical 
ventilation 
21 (72.4%) 5 (17.2%) 16 (55.2%) 0.1 
Mechanical ventilation days 
none 8 (27.6%) 0 8 (27.6%) 0.03 
<1 day 2 (6.9%) 0 2 (6.9%) 
1 day 3 (10.3%) 2 (6.9%) 1 (3.4%) 
2 - 3 days 3 (10.3%) 1 (3.4%) 2 (6.9%) 
4 - 7 days 9 (31%) 0 9 (31%) 
>7 days 4 (13.8%) 2 (6.9%) 2 (6.9%) 
Received inotropes 6 (20.7%) 5 (17.2%) 1 (3.4%) < 0.0001 
Blood transfusion 14 (48.3%) 4 (13.8%) 10 (34.5%) 0.1 
PICU intervention 
(surgery or dialysis) 
Dialysis (n=1) or 
surgery (n=7) 
8 (27.6%) 3 (10.3%) 5 (17.2%) 0.1 
Cardiac arrest 5 (17.2%) 5 (17.2%) 0 < 0.0001 
 
The most common reason for PICU admission was found to be apnoea (Table 2). At the time 
of discharge, respiratory illnesses were the cause of 48.2% of the admissions and infectious 
illnesses were associated with 86.2% of the admissions to PICU (Table 2).  
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The vast majority of admissions secondary to infective causes had no identified microbial 
diagnosis; one infant was found to have a growth of Group B streptococcus on blood culture. 
One child was treated as a presumed Bordetella pertussis infection. Although this is a vaccine 
preventable infection, this child had received three doses of the EPI-funded Bordetella 
pertussis vaccination. Respiratory syncytial virus (RSV) was isolated in four (13.8%%) patients, 
three of whom were diagnosed with respiratory tract infections. Two of these patients were 
admitted during the RSV season and none of the 29 infants received palivizumab. 
Table 2: Reason for Admission and Discharge Diagnosis (n=33 admissions) 
Reason for Admission  
Apnoea 13 (39.4%) 
Respiratory failure 8 (24.2%) 
Septic shock 5 (15.2%) 
Hypovolaemic shock 3 (9.1%) 
Cardiac arrest  2 (6.1%) 
Other  2 (6.1%) 
Discharge Diagnosis  
Pneumonia 11 (33.3%) 
Bronchiolitis 1 (3%) 
Upper airway obstruction 2 (6.1%) 
Sepsis 9 (27.3%) 
Meningitis 4 (12.1%) 
Other 6 (18.2%) 
 
Course 
Invasive ventilation 
Twenty- four of the 33 admissions (72.7%) were intubated and mechanically ventilated during 
the course of the PICU stay. Table 1 presents total duration of PICU stay and mechanical 
ventilation for the included infants.  
Procedures 
One child required emergency dialysis and seven infants underwent surgery during their 
PICU admission (Table 3). 
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Table 3: Surgical procedures and outcomes (n=7) 
Infants admitted immediately following emergency surgery 
Procedure Indication  Outcome 
Laparotomy Incarcerated inguinal hernia Survived 
Tracheostomy (n=2) Upper airway obstruction (n=2) Survived (n=2) 
Laparotomy Abdominal distension and feed intolerance Survived 
Emergency surgery performed during PICU stay 
Procedure Indication  Outcome 
Patent ductus arteriosus 
ligation Cardiac failure Survived 
Laparotomy Incarcerated hernia Died 
Removal of 
ventriculoperitoneal shunt 
and placement of external 
ventricular drain Ventriculitis Survived 
 
Inotropes 
Six of the 33 admissions (18.2%) received inotropes and five of these infants died. None of 
the infants who did not receive inotropes died (p < 0.0001; Table 1).  
Blood transfusions 
Fourteen (48.3%) infants received blood transfusions (Table 1). Infants who received blood 
transfusions had lower median (IQR) birth weight (1170 (1000 - 1715) g vs. 2300 (1620 - 2410) 
g; p = 0.01) and younger median (IQR) gestational age (29.5 (28 – 32) weeks vs 33 (31 – 36) 
weeks; p = 0.02) compared to those who did not receive transfusions. The median 
haemoglobin for which a transfusion was administered was 8.5 g/dL. The timing of these 
blood transfusions following admission to PICU is unknown.  
 
Cardiac arrests 
Five of the infants admitted to the PICU were successfully resuscitated following at least one 
cardiac arrest in the PICU (Table 4). Despite this, all of these infants eventually died in PICU. 
One of these events occurred in an infant during a second admission to the PICU.  
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Table 4: Cardiac arrests in PICU (n=5) 
Gestational 
age (weeks) 
Birth weight 
(grams) 
Reason for admission 
28 800 Septic shock 
28 1180 Septic shock 
32 1800 Apnoea 
34 2490 Hypovolaemic shock 
36 2410 Septic shock 
 
Outcomes 
Five (17.2%) of the 29 infants died in PICU. The standardised mortality ratio (actual/mean 
predicted mortality, SMR) was 1.39.  
Higher PIM2 score on admission; a longer period of mechanical ventilation; receipt of 
inotropes and cardiac arrest were associated with PICU mortality on univariate analysis (Table 
1). However, none of these associations were found to be independent predictors of mortality 
on multiple regression analysis. There was no difference in gestational age or birth weight 
between infants who died vs. those who survived (Table 1; p > 0.4). 
7.6 Discussion 
This is the first study performed in sub-Saharan Africa looking at rehospitalisations of 
premature infants in any setting. Over the six-month period, 29 infants were admitted to the 
PICU. Although premature infants in the first six months of life formed only 5.7% of the total 
number of admissions in the study period, 11.6% of the deaths in the unit were infants 
included in this study.  
 
A higher PIM2 score on admission was associated with death during PICU admission (p=0.03), 
and the SMR of 1.39 shows that the actual mortality was greater than the predicted mortality. 
As the PIM2 score is calculated on admission to PICU, it is potentially a useful indicator for 
early identification of those infants who have an increased risk of mortality. The PIM2 score 
has been shown to accurately predict mortality internationally and has been validated for use 
in the PICU at RCWMCH[21]. 
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All of the children who had an initial successful resuscitation following a cardiac arrest 
eventually demised in PICU. All of these infants also required inotropes in PICU while none of 
the infants who did not receive inotropes died.  
 
The receipt of inotropes (p < 0.0001), a longer period of mechanical ventilation days (p = 0.03) 
and cardiac arrest in PICU (p < 0.0001) were all associated with mortality on univariate 
analysis. However, with multiple regression analysis, none of these factors were found to be 
independent predictors of mortality. No correlation was found between birth weight or 
gestational age and mortality (p ≥ 0.4). 
 
Apnoea and respiratory failure were identified as the reason for admission in 39.4% and 
24.2%, respectively, of admissions to PICU. This is unsurprising as the literature review 
showed similar findings[11,12,14,22]. Shock was found to be another common reason for 
admission, specifically septic shock in 15.2% and hypovolaemic shock in 9.1% of the 
admissions. On discharge, infections were noted to be the final diagnosis in 75.8% of 
admissions. These infections include pneumonia (33.3%), sepsis (27.3%), meningitis (12.1%) 
and bronchiolitis (3%), which is in keeping with the findings of Mukhopadhyay et al.[18] in a 
study done in India. RSV infection was isolated in three (9.1%) of the patients diagnosed with 
respiratory tract infection. Underwood et al[14]. and Hong et al[12]. both found that RSV-related 
illness was a significant cause for rehospitalisation.   
 
In this study group, 54.5% of the PICU admissions were for four days or longer, with 21.2% of 
these lasting longer than 7 days. In 2014, Mourani et al[7]. reported that in the first four and 
a half years of life, 49% of the 96 premature infants admitted to PICU required mechanical 
ventilation for an average of 11.6 days. In our study, intubation and mechanical ventilation 
was required in a greater percentage (72.4%) of admissions, but only four were ventilated for 
more than seven days. Gunville et al[17]. report that premature infants generally have a longer 
length of stay in PICU and utilise more hospital resources than infants born at term. Although 
this study does not have the capacity to show similar findings, it does suggest that premature 
infants utilise a significant amount of hospital resources.  
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Infants of a lower gestational age at birth or those with a lower birth weight were significantly 
more likely to require blood transfusion (p ≤ 0.05). This was also found by Mukhopadhyay et 
al.[18] in infants born weighing less than 1000 g at birth. It may be beneficial to routinely 
prescribe haematinics to all premature infants on discharge from the neonatal unit as iron 
supplementation has been found to decrease the risk of developing iron deficiency anaemia 
in preterm infants[23]. 
 
The majority of the infants were male, in keeping with the findings of Tseng et al.[5] and 
several other studies[9,12,24].  Seventeen (58.6%) of the infants weighed 1500 g or more at birth 
and seventeen (58.6%) of the infants were born at or after 32 weeks of gestation. Although 
one study[10] reported similar findings, most literature suggests that a lower GA or birth 
weight increases the risk of rehospitalisation[5,13-15,25].   Our findings suggest that moderate to 
late preterm infants are also susceptible to the consequences of prematurity, in this setting 
and should therefore receive the same care and follow-up as extremely preterm infants.  
  
More than half of the infants admitted to the PICU had an initial neonatal length of stay longer 
than four weeks, although only 27.6% of infants were noted to have significant morbidity on 
neonatal unit discharge.   
 
Thirty eight percent of infants in our study were missing immunisations. This is concerning 
in terms of public health and preventative health care. Although Bordetella pertussis 
infection was presumed in one case, the affected infant had received three doses of the 
vaccine for Bordetella pertussis. No other EPI administered vaccine-preventable causes of 
admission were identified. RSV prophylaxis (palivizumab)is not routinely available in the 
study region, despite being recommended during RSV season for children born at a 
gestational age below 36 weeks, who are younger than 6 months [26]. Only one of the three 
children affected by RSV-related respiratory illnesses would have fulfilled the criteria to 
receive RSV prophylaxis, if it were available. Therefore one of the 33 (3.0%) admissions was 
potentially avoidable had palivizumab been available in the neonatal units during the study 
period. 
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It was fairly reassuring to find that all the infants were HIV uninfected on admission, including 
those at risk for Mother-To-Child transmission, and the vast majority were receiving exclusive 
breastmilk feeds. Despite this, only 48.3% of the infants were noted to be growing well and 
31% of the infants had either lost weight since discharge from the neonatal unit or were 
categorized as malnourished.  Most of the infants were admitted more than a month after 
discharge from the neonatal unit. Early identification and timeous intervention in infants that 
are not growing well is required to optimise the health and well-being of all premature 
infants.   
 
Improved access to antenatal care and family planning services to decrease the incidence of 
prematurity has to become, and remain, a priority for all those involved in the provision of 
health care. Health promotion with regard to breastfeeding support, regular visits to primary 
health care facilities for monitoring of growth and wellness, as well as promoting 
immunisations provided through the EPI program needs to become a major focus of the care 
of all infants, and in particular, those born preterm.   
 
Study Limitations 
This study has several limitations. Data was collected only on premature infants over a period 
of six months. The lack of a control group increases the likelihood of confounding bias within 
this study. The small study sample as well as the short study period affects the validity of the 
findings of this study. The small study sample may be a reflection of data collection occurring 
when the incidence of respiratory viral infections were possibly fewer. The information 
related to the neonatal admission was mostly found in the RTHB and some details regarding 
the neonatal admission may have been incomplete, resulting in potential information bias. 
This study also has not included any infants who may have been rehospitalised in a PICU in 
another hospital or other districts in South Africa. 
7.7 Conclusions and recommendations 
Over a six-month period, 5.7% of the total admissions and 11.6% of the deaths in PICU were 
of premature infants within the first six months of life, with a SMR >1. Factors associated with 
mortality on univariate analysis were: PIM2 score, receipt of inotropes, duration of 
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mechanical ventilation and cardiac arrest in PICU; however independent predictors of 
mortality could not be identified in this small cohort. These findings suggest that premature 
infants utilise a considerable proportion of PICU resources and are at increased risk of serious 
illness and mortality. Further research is required to clarify the extent of resource utilisation, 
morbidity and overall mortality in this population of infants.  
 
Prematurity remains a significant risk factor for morbidity, and further studies are required to 
gain insight into the true burden of disease associated with prematurity in Southern Africa, 
including the healthcare resource consumption outside the PICU.  Preventative health care is 
a priority, specifically in terms of decreasing the incidence of premature deliveries as well as 
improving health care for all mothers, infants and children.   
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A Description of Premature and Ex-Premature Infants 
Admitted to a Paediatric Intensive Care Unit in the First 
Six Months of Life 
Care of the premature newborn is an ever-evolving medical field. There have been dramatic 
advancements in the knowledge and interventions related to care of any premature infant. Survival is 
not only a possibility, but most often the expectation, in many situations once considered to be futile. 
However, the risk in these cases is that a premature infant may survive with significant morbidity and 
demands on the health care system and family in the future.  
There is very little data available worldwide regarding premature infants that require readmission to 
a neonatal or paediatric intensive care unit (PICU). The intention of this study is to look specifically at 
unplanned admissions of preterm infants to PICU at Red Cross War Memorial Children’s Hospital 
(RXH). The purpose is two-fold. Firstly, describing the incidence and course of these admissions and 
secondly, to identify risk factors in preterm infants that increase the likelihood of a long stay in PICU 
or mortality. Our hope is that data from this study may be used to identify infants who are at increased 
risk of serious illness or death after discharge from a neonatal unit. Unfortunately, this study will not 
include infants who demise at home or prior to admission into this unit. As a result, there is potential 
to underestimate the risk of morbidity and mortality in premature infants.  
In addition to this, we will compare the mortality rate as well as the length of stay of premature infants 
to all children admitted to the PICU in the same time period. We will also briefly report what 
percentage of the admissions to the PICU are premature infants within this time period.  
This is valuable information as it addresses the impact of preterm births within the health care system 
in Cape Town, South Africa. It may also provide insight into the outcome of preterm infants and flag 
any factors that potentially increase the likelihood of severe illness after discharge from a neonatal 
unit. This data would be used to improve protocols and long-term care plans for premature babies.  
Definitions 
As per the World Health Organisation (1), the classification of premature and underweight infants is 
as follows: 
o <28 weeks: extremely preterm 
o 28 to <32 weeks: very preterm 
o 32 to <37 weeks: moderate to late preterm  
o <1000g: extremely low birth weight (ELBW) 
o 1000g to <1500g: very low birth weight (VLBW) 
o 1500g to <2500g: low birth weight (LBW) 
 
Gestational age (GA) of any infant is determined using one of three options which include antenatal 
ultrasonography, calculations based on last menstrual period and scoring based on physical 
examination of the neonate, such as the Ballard Score. An early ultrasound done up to 23 completed 
weeks is considered to be the most accurate estimate of GA. Soon after birth, GA of a child is 
determined by the attending clinician based on one or more of the above-mentioned assessments 
and is often inaccurate. 
  Page 48 of 76 
 
The following scores are used worldwide and will be used as indicators in this study: 
• The Paediatric Index of Mortality (PIM) is a score that was designed to estimate mortality risk 
during an admission to a PICU (2). The score uses data from the time of admission and is 
validated for monitoring of quality of care provided by a PICU. The score was revised in 2003 and 
is now referred to as PIM2. 
• The Paediatric Risk of Mortality Score (PRISM) is designed for use in any PICU and uses various 
physiologic variables to assist with mortality risk assessment (3). 
Literature review 
Currently, in Cape Town West Metro, there is no data regarding outcome of patients discharged 
from the neonatal units. A search of the literature revealed some interesting research that I will 
explore further.  
Readmission Diagnoses 
The reasons for hospital readmissions in premature infants have been quite extensively researched. 
Several common diagnoses have been identified in various studies, as discussed below. Kuzniewicz et 
al. published a literature review focused on readmissions and emergency department visits in 
moderate preterm, late preterm and term infants in the first thirty days post discharge (4). The studies 
reviewed were all performed in the United States of America, Canada and the United Kingdom. They 
found that the commonest cause for readmission was for jaundice and feeding problems in the late 
pre-term, early term and term patients. But after excluding these admissions, in all the subgroups, the 
most common reason for readmission was found to be presumed sepsis.  
A retrospective study on infants that required readmission in the first two weeks after discharge from 
a neonatal unit (NU) in various centers in the USA showed similar results (5). They found, once again, 
that feeding difficulty and jaundice were the most common reasons for readmission in infants with a 
gestational age above 33 weeks. A study of the outcomes of infants born before 28 weeks GA in 
several centers in Quebec, Canada (6) found that readmission was most commonly due to a 
respiratory illness. Other reasons for readmission included surgery, gastro-intestinal/nutrition 
problems, other infections and neurological problems. These children were followed up to a corrected 
age of 18 months. 
PICU readmission of premature babies 
Admission to any intensive care unit (ICU) carries significant morbidity and mortality risks. Research 
regarding readmissions of premature babies specifically to PICU is limited. A study done in Denver, 
Colorado by Cameron et al (7) in 2010 looked at all children below the age of 2 years that required 
admission to a PICU. They found that preterm infants were at an increased risk of admission secondary 
to respiratory illness in their centers. Notably, preterm infants required longer PICU and hospital stay, 
and utilised more resources than term infants.  
Mourani et al (8) found that nearly 1 in 5 premature babies required readmission to an ICU after 
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discharge from a neonatal intensive care unit (NICU) over the next 4.5 years. 
A study done in India found an 11% mortality rate and a 44% readmission rate in a group of extremely 
low birth weight infants who were followed up for a period of 2 years (9). Although this study was not 
looking specifically at readmissions to ICU, these results are alarming.  
Unfortunately, there is limited data regarding readmissions of premature infants to ICU, but there are 
some identifiable risk factors for readmission of these children over the next few years of their lives. 
Kuzniewicz et al (4) found that the population at highest risk of readmission was the moderate preterm 
infants. Some identifiable risk factors for readmission in their study group included preterm infants 
and those with a length of stay over 5 days in a neonatal unit. But other evidence seems to be more 
ambivalent regarding a relationship with length of stay and risk of readmission (10). Moderate 
preterm infants are twice as likely to be readmitted when compared to term infants up to the age of 
5, especially with exposure to passive smoking, early respiratory infections, and those with a family 
history of asthma (11). On the other hand, late-preterm infants are also at increased risk of 
readmission and mortality (12). 
There is also some evidence to indicate that those born by caesarean section have a decreased risk of 
readmission (13). Infants who required mechanical ventilation are at increased risk of readmission to 
hospital (14)- in particular, males, those with increased duration of neonatal admission, or prolonged 
oxygen therapy, and those with severe intracranial haemorrhage. 
A review done in Australia by Doyle et al (15) in 2002 looked specifically at infants with extremely low 
birth weight (ELBW) below 1000 g in studies done from 1980 to 1997. They found that most of the 
studies reported readmission rates close to or above 50%, although severity of the illness wasn't 
mentioned. This increased risk persisted into later childhood as well. Infants with bronchopulmonary 
dysplasia (BPD) were also found to have higher rates of readmission and more likely to require 
multiple readmissions. Some other identifiable risk factors included male gender, smoking in 
pregnancy and chronic lung disease (16). In infants born before 28 weeks GA, the likelihood of 
readmission was increased in socially disadvantaged groups. There was no identifiable increase in risk 
related to birth weight or GA. Respiratory infection was the commonest diagnosis in patients requiring 
rehospitalisation. Luu et al (6) also found a 46% readmission rate in infants born below 28 weeks GA. 
Infants with BPD, particularly those on home oxygen, and those with severe brain injury, prolonged 
neonatal stay and using an apnoea monitor at home were at increased risk of readmission when they 
were followed up until 18 months corrected age. The development of BPD has a significant morbidity 
throughout childhood (17, 18). Some other identifiable risk factors include shunt surgery for 
hydrocephalus, necrotising enterocolitis (stage II or worse) and spontaneous perforation of the 
gastrointestinal tract (17).   
In summary, it seems that ELBW and extremely premature infants tend to be at increased risk of 
readmission (up to 50%). Several studies identified chronic lung disease/BPD as a common 
characteristic in infants requiring readmission. This seems consistent even with follow-up into the 
second year of life. There is some discrepancy in data related to the impact of length of stay in the 
neonatal unit.  
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Another important consideration in the care of preterm infants is discharge criteria. These criteria 
need to balance the safety of the infant with the cost of medical care. Both Seki et al (19) and Picone 
et al (20) indicates that there is a safe approach to early discharge of premature infants, particularly 
in a first world setting. Unfortunately, there is very limited research comparing discharge criteria and 
risk of readmission. There is some risk identified with a length of stay less than two days with an 
increased likelihood of missed comorbidities and complications in all admissions (21).  
Seki et al (19) studied the 3 month and 1 year readmission rates of preterm infants (22 to 34 weeks 
GA) in a NICU in Japan. These infants were discharged regardless of age or weight if they were clinically 
well, free of apnoeas and bradycardia for a week, gaining weight with lactation and with good 
temperature regulation and home environments. They found that 9.5% of their infants in total, but 
26.9% of those with GA less than 26 weeks, required readmission. Considering the low rate of 
readmission, their criteria for discharge were considered appropriate.  
Picone et al (20) found that in their center it was appropriate to discharge clinically well infants at a 
mean weight close to 1900g if the infant was born under 32 weeks GA and/or a birth weight lower 
than 1500g. Only 8 of the 122 infants included in the study required readmission within 33 days post 
discharge. These patients were not followed up beyond this period.  
Summary 
Although limited data is available, readmissions rates are consistently higher in premature infants, 
some up to 50%. There seem to be risk factors that increase the likelihood of readmission. These 
include early preterm infants, BPD and those requiring mechanical ventilation in NICU. One of the 
above studies also found that socio-economic circumstance of the family may play a part as well. 
Length of stay in a NU seems to have an influence, although this seems to vary with gestational age. 
Identifying appropriate and safe discharge criteria may decrease the likelihood of readmission. 
Respiratory illness and presumed sepsis seem to be the most common diagnoses in infants requiring 
readmission. Feeding difficulty and jaundice are more common readmission diagnoses in late preterm 
infants. Unfortunately, it is difficult to extrapolate these results to a South African setting. Health 
resource limitations may influence early neonatal discharge; and family socio-economic circumstances 
may impact readmission rates.  
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Purpose of the Study 
i. To describe the unplanned admissions of premature or ex-premature babies to RXH PICU within 
the first six months of life. 
ii.  To identify risk factors associated with prolonged PICU admission and/or mortality of 
premature or ex-premature infants admitted to RXH PICU.  
Methodology 
Study Design 
A longitudinal observational study of all babies admitted to RXH PICU with the history of premature 
birth. Only babies with a chronological age of six months or less on PICU admission will be included. 
Data will be collected prospectively in a period from March 2016 to October 2016.  
Setting 
Within the Cape Town West Metro service, Mowbray Maternity Hospital (MMH), New Somerset 
Hospital (NSH) and Groote Schuur Hospital (GSH) bear the brunt of secondary and tertiary care of 
neonates. Unwell newborns are admitted directly into the neonatal unit. Once they are determined 
to be safe for discharge, they are referred to the Maternity-Obstetric Units (MOUs) in local community 
health centers if they are considered to be low-risk infants. High-risk infants are followed up at MMH, 
where specialists are on hand to deal with any major concerns.  
If these infants require readmission for any reason, they are generally admitted to the nearest 
paediatric unit. In the Cape Town West Metro district, within the state health sector, the only 
paediatric intensive care unit is within the Red Cross War Memorial Children’s Hospital. RXH is a South 
African tertiary academic children’s hospital which has a multidisciplinary, 22 bed medical and surgical 
PICU where the study will be performed. There are approximately 400 ex-premature infants admitted 
to this unit every year.  
Enrolment of patients 
Patients will be enrolled by the student researcher who will review admissions in the PICU at least 
five days a week and collect data as detailed below. We anticipate that there will be up to 200 
patients enrolled in this study.  
Inclusion criteria 
• All babies admitted to RXH PICU  
• with the history of being born premature at GA of <37 weeks at birth  
• and have been discharged from a neonatal unit  
• and have a chronological age of six months or less on RXH PICU admission 
 
 
Exclusion criteria 
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• All premature babies admitted to RXH PICU directly from a neonatal unit for ongoing specialized 
tertiary care before being discharge from the NICU. 
Interventions 
Routine PICU care will be provided to all patients during their PICU stay. No study intervention will be 
done besides routine care. 
Data collection 
Data will be collected prospectively from patient folders, PICU database, discharge summaries and 
Road to Health booklets. The Road to Health Booklet (RTHB) is a tool to record information relating to 
growth and development of a child. Some useful information it provides includes birth and perinatal 
history, immunisation status, growth charts and a record of outpatient and inpatient visits.  
PICU data will include: 
• Reason for PICU admission e.g. apnoea/shock/respiratory failure/dehydration 
• PICU discharge diagnosis 
• Length of stay in PICU 
• Interventions in PICU: e.g., ventilation, inotropes 
• PIM2 and PRISM score in PICU admission 
• Admission age, weight, haemoglobin 
• Outcome: Survival to PICU discharge, length of stay, length of ventilation days 
• Previous admissions to PICU 
We will collect data on birth history and NU care to identify risk factors for PICU readmission. Neonatal 
records of patients from GSH or MMH should be available, but there may be difficulties accessing 
records of patients from other institutions.  
Neonatal and general data will include: 
•  Gender 
•  GA and birth weight 
•  Neonatal admission: length of stay, discharge weight,  
•  Feeding choice 
•  Congenital abnormalities or syndrome 
•  Mode of delivery 
•  HIV status: exposure and infection 
•  Immunisation Status 
The available information will be collected using the data capture sheet attached and stored on a 
Microsoft Excel spreadsheet. A study number linked to the allocated hospital number will be used to 
identify patients, thereby maintaining patient confidentiality. The hospital number will be used to 
identify multiple readmissions of the same patient to avoid duplication of the same patient, but all 
admissions will be recorded.  
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Data Analysis 
Statistical analysis will be performed by Professor Brenda Morrow. Data will be tested for normality 
using Shapiro Wilks W test, and descriptive statistics presented as appropriate for distribution. 
Univariate analysis will be conducted to assess associations between collected data and binary 
outcome measures, using t tests, Mann Whitney U tests and chi-square tests according to normality 
and type of data. Variables found to be associated with the outcome of mortality on univariate analysis 
will be entered into a stepwise logistic regression model to determine independent risk factors. 
Correlation coefficients between continuous variables and length of ICU stay will be analysed using 
Spearman R or Pearson Product Moment tests according to distribution. Statistical significance will be 
defined as p <0.05. 
Risks and Benefits 
This is a descriptive study and patients will not be exposed to any interventions, nor will patient 
management be affected by the information collected during the study. As such, there is no specific 
physical risk or benefit to any of the patients included in the study.  The following measures will be in 
place to protect patient confidentiality and anonymity. Patient names will not be collected, instead 
patients will be allocated unique study numbers linked to the hospital folder number and related to 
chronological entry into the study. This number will be separate from the hospital or ICU admission 
number. The link to both numbers will be stored in password protected documents. All of the data 
will be stored on a database on a private computer. The data and statistics will only be accessible to 
the principal investigators.  
In the long term, it is hoped that identifying any factors that increase risk of severe illness may lead to 
more appropriate follow-up and monitoring of premature infants.  
The principle of autonomy cannot be applied to these young infants, but this is the most vulnerable 
and, as such, valuable time to assess this group of patients. For the information relevant to this study, 
it is difficult to extrapolate data from older children or adults. Therefore, it is necessary to include this 
group of patients.  
Informed Consent 
As this is a descriptive study, there is no alteration to treatment for patients included in the study. 
Information will be collected only from patient folders, the PICU database, discharge summaries and 
Road to Health booklets. There will not be an interview with the parents or legal guardians of the 
patients.  
Informed consent will be taken from the parents or legal guardian of the patient. A hospital translator 
or a PICU staff member will be available to assist with translation if required.  
Cost 
Children will receive standard PICU and hospital care. There will be no additional laboratory or hospital 
expenses.  
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Ethical considerations 
Full approval will be obtained from the Human Research Ethics Committee of the Faculty of Health 
Sciences, University of Cape Town and Red Cross War Memorial Children’s Hospital.  
We understand that the privacy of these infants and their families is of the utmost importance. As 
detailed above, every effort will be made to maintain patient confidentiality. All research will adhere 
to the requirements stated in the Declaration of Helsinki, 2013. 
Outcome 
Data will be presented at a National Paediatric conference and will be published in a peer reviewed 
journal. 
Limitations 
The data for the study will be collected from patient folders, discharge summaries and RTHBs. The 
information available will be heavily reliant on thorough note-keeping from both the PICU and the 
neonatal units. As a result, the data collected may be incomplete and affect the final analysis of 
available information related to PICU admission. 
Infants from MMH, NSH and GSH neonatal units should have adequate data, but the information from 
other units may not be easily available. This will affect the interpretation of data from the admission 
to the neonatal unit.  
As we are not collecting data on infants who demise at home or prior to admission to PICU at RXH, 
the data may underestimate the actual morbidity and mortality of premature infants after discharge 
from a neonatal unit.  
Children will be recruited into this study based on their GA. As discussed earlier, GA is determined 
using information from antenatal ultrasounds, or last menstrual period of the mother or a score based 
on physical examination. These estimates are often inaccurate as the above criteria are fairly 
unreliable and rely heavily on clinician skill or the mother’s memory.  
 
The aim of this study is to describe the incidence and course of unplanned readmissions, within the 
first six months of life, of infants born preterm to the paediatric intensive care unit at Red Cross War 
Memorial Children’s Hospital. It may provide insight into the impact of premature infants on the 
health care system, as well as the outcome of these infants. In addition, the study may identify risk 
factors that increase the likelihood of a long stay in PICU or mortality. The data collected has the 
potential to improve current protocols and long-term care of premature babies.  
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Appendix 3: Data collection form 
PICU Admission 
Discharge Diagnosis (A) 
Respiratory Pneumonia Bronchiolitis Upper Airway 
obstruction 
Aspiration Asthma 
GIT Bowel Obstruction Gastroenteritis NEC 
CVS Congenital Heart Disease Myocarditis 
Neurological Seizures Meningitis Hydrocephalus Other 
Bacterial sepsis Group B Strep Nosocomial Other 
Viral Adenovirus RSV Other 
Vaccine-
preventable 
Yes No Diag: 
Non-medical Trauma Elective Surgery Other 
Other  
 
Reason for admission (B) 
CVS Cardiac Failure Cardiogenic Shock Cyanotic Spells  
Respiratory Respiratory failing needing intubation and 
ventilation 
Requiring CPAP 
Neurological Seizures Decreased level of consciousness 
Shock Septic Shock Hypovolaemic shock Cardiogenic Shock Other 
Other Electrolyte 
derangements 
Apparent life threatening event Apnoea 
Non-medical Trauma Elective Surgery 
Other  
PICU admission (C) 
Outcome Demised in PICU Discharged from PICU 
Length of stay in 
PICU 
>7 days 4-7 days 2-3 days 1 day <1 day 
Resp support  IPPV CPAP/NPO2 Room Air 
Ventilation Days >7 days 4-7 days 2-3 days 1 day <1 day 
CVS support  Inotropes No inotropes 
Anaemia Transfused Anaemia Not anaemic 
Other interventions Dialysis Surgery Other 
PIMS Score  
Previous PICU 
admission 
 
Other  
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Patient characteristics and Neonatal Unit (NU) Admission (D) 
Gender Male Female 
Gestational Age  
 
 
Mode of delivery NVD: Inborn or Outborn Caesarean Section 
Actual age at 
admission 
<1 month 1-2 months 2-4 months 4-6 months 
Corrected age 35-<37weeks 37->40 weeks 40 wks to <1 month 1-<3 months >/= 3 month 
Weight at 
admission 
<2 kg 2-<4 kg 4-<6 kg >6 kg 
Birth weight  
 
 
 
Current weight Weight below -2 Z score Weight above -2 Z score 
Trend since NU 
discharge 
Falling off z-score trend Following trend z-score 
Length of stay in 
NU 
<4 days 4-<7 days 1-2 weeks 2-4 weeks >4 weeks 
NU: D/C wt 
 
 
 
Time since 
discharge from 
neonatal unit 
<1 week 1-2 weeks > 2 weeks to 1 month  >1 month > 2 months  
Feeding at 
readmission 
Breast  Formula Mixed Non-milk feeds/water introduced 
Immunisation 
status 
UTD Not UTD Delayed, if yes, how long? Not documented 
HIV Status Negative Exposed, -ve Infected, HAART Infected, no HAART 
Other  
 
Morbidities identified in the Neonatal Unit (E) 
Respiratory Intubation and 
ventilation >72 
hours 
Chronic lung 
disease (required 
oxygen at 36w 
corrected age) 
On home oxygen 
Congenital 
abnormality 
Cardiac lesions Syndromic Other 
Pre-discharge 
cranial US 
Normal Periventricular 
leucomalacia 
Gr 3 - 4 IVH  Other abnormality 
Complications Moderate to 
severe HIE 
Severe NNJ above 
exchange value 
Sepsis NEC Cardiac 
surgery 
Other 
surgery 
Other Late infection       Retinopathy of prematurity     
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Appendix 4: Instructions to authors of chosen journal 
South African Journal of Child Health 
The South African Journal of Child Health is an online, quarterly, peer reviewed medical journal 
covering all aspects of child health. 
 
Author Guidelines 
Author Guidelines 
  
Please view the Author Tutorial for guidance on how to submit on Editorial Manager.  
  
To submit a manuscript, please proceed to the SAJCH Editorial Manager website: Editorial 
Manager 
  
To access and submit an article already in production, please see the guidelines here. 
  
Author Guidelines 
Please take the time to familiarise yourself with the policies and processes below. If you still 
have any questions, please do not hesitate to ask our editorial staff (tel.: +27 (0)21 532 
1281, email: submissions@hmpg.co.za). 
  
  
Authorship 
Named authors must consent to publication. Authorship should be based on: (i) substantial 
contribution to conceptualisation, design, analysis and interpretation of data; (ii) drafting or 
critical revision of important scientific content; or (iii) approval of the version to be 
published. These conditions must all be met for an individual to be included as an author 
(uniform requirements for manuscripts submitted to biomedical journals; refer 
to www.icmje.org) 
  
If authors’ names are added or deleted after submission of an article, or the order of the 
names is changed, all authors must agree to this in writing. 
  
Please note that co-authors will be requested to verify their contribution upon submission. 
Non-verification may lead to delays in the processing of submissions. 
  
Author contributions should be listed/described in the manuscript. 
Conflicts of interest 
Conflicts of interest can derive from any kind of relationship or association that may 
influence authors’ or reviewers’ opinions about the subject matter of a paper. The existence 
of a conflict – whether actual, perceived or potential – does not preclude publication of an 
article. However, we aim to ensure that, in such cases, readers have all the information they 
need to enable them to make an informed assessment about a publication’s message and 
conclusions. We require that both authors and reviewers declare all sources of support for 
their research, any personal or financial relationships (including honoraria, speaking fees, 
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gifts received, etc) with relevant individuals or organisations connected to the topic of the 
paper, and any association with a product or subject that may constitute a real, perceived 
or potential conflict of interest. If you are unsure whether a specific relationship constitutes 
a conflict, please contact the editorial team for advice. If a conflict remains undisclosed and 
is later brought to the attention of the editorial team, it will be considered a serious issue 
prompting an investigation with the possibility of retraction. 
  
Research ethics committee approval 
Authors must provide evidence of Research Ethics Committee approval of the research 
where relevant. Ensure the correct, full ethics committee name and reference number is 
included in the manuscript. 
If the study was carried out using data from provincial healthcare facilities, or required 
active data collection through facility visits or staff interviews, approval should be sought 
from the relevant provincial authorities. For South African authors, please refer to the 
guidelines for submission to the National Health Research Database. Research involving 
human subjects must be conducted according to the principles outlined in the Declaration of 
Helsinki. Please refer to the National Department of Health’s guideline on Ethics in Health 
research: principles, processes and structures to ensure that the appropriate requirements 
for conducting research have been met, and that the HPCSA’s General Ethical Guidelines for 
Health Researchers have been adhered to. 
  
Clinical trials 
Since 1st December 2005, all clinical trials conducted in South Africa have been required to 
be registered in the South African National Clinical Trials Register. The SAJCH therefore 
requires that clinical trials be registered in the relevant public trials registry at or before the 
time of first patient enrollment as a condition for publication. The trial registry name and 
registration number must be included in the manuscript.  
  
Protection of rights to privacy 
Patient 
Information that would enable identification of individual patients should not be published in 
written descriptions, photographs, radiographs and pedigrees unless the information is 
essential for scientific purposes and the patient (or parent or guardian) has given informed 
written consent for publication and distribution. We further recommend that the published 
article is disseminated not only to the involved researchers but also to the 
patients/participants from whom the data was drawn. Refer to Protection of Research 
Participants. The signed consent form should be submitted with the manuscript to enable 
verification by the editorial team. 
  
Other individuals 
Any individual who is identifiable in an image must provide written agreement that the 
image may be used in that context in the SAJCH. 
  
Copyright notice 
Copyright remains in the Author’s name. The work is licensed under a Creative Commons 
Attribution - Noncommercial Works License. Authors are required to complete and sign an 
Author Agreement form that outlines Author and Publisher rights and terms of publication. 
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The Agreement form should be uploaded along with other submissions files and any 
submission will be considered incomplete without it [forthcoming]. 
  
Material submitted for publication in the SAJCH is accepted provided it has not been 
published or submitted for publication elsewhere. Please inform the editorial team if the 
main findings of your paper have been presented at a conference and published in abstract 
form, to avoid copyright infringement. The SAJCH does not hold itself responsible for 
statements made by the authors. The corresponding author should also indicate if the 
research forms part of a postgraduate short report, dissertation or thesis. 
Previously published images 
If an image/figure has been previously published, permission to reproduce or alter it must 
be obtained by the authors from the original publisher and the figure legend must give full 
credit to the original source. This credit should be accompanied by a letter indicating that 
permission to reproduce the image has been granted to the author/s. This letter should be 
uploaded as a supplementary file during submission. 
  
Privacy statement 
The SAJCH is committed to protecting the privacy of its website and submission system 
users. The names, personal particulars and email addresses entered in the website or 
submission system will not be made available to any  third party without the user’s 
permission or due process. By registering to use the website or submission system, users 
consent to receive communication from the SAJCH or its publisher HMPG on matters relating 
to the journal or associated publications. Queries with regard to privacy may be directed 
to publishing@hmpg.co.za. 
  
Ethnic/race classification 
Use of racial or ethnicity classifications in research is fraught with problems. If you choose 
to use a research design that involves classification of participants based on race or 
ethnicity, or discuss issues with reference to such classifications, please ensure that you 
include a detailed rationale for doing so, ensure that the categories you describe are 
carefully defined, and that socioeconomic, cultural and lifestyle variables that may underlie 
perceived racial disparities are appropriately controlled for. Please also clearly specify 
whether race or ethnicity is classified as reported by the patient (self-identifying) or as 
perceived by the investigators. Please note thatit is not appropriate to use self-reported or 
investigator-assigned racial or ethnic categories for genetic studies. 
  
Continuing Professional Development (CPD) 
SAJCH is an HPCSA-accredited service provider of CPD materials. Principal authors can earn 
up to 15 CPD continuing education units (CEUs) for publishing an article; co-authors are 
eligible to earn up to 5 CEUs; and reviewers of articles can earn 3 CEUs. Each 
month, SAJCH also publishes a CPD-accredited questionnaire relating to the academic 
content of the journal. Successful completion of the questionnaire with a pass rate of 70% 
will earn the reader 3 CEUs. Administration of our CPD programme is managed by Medical 
Practice Consulting. To complete questionnaires and obtain certificates, please visit MRP 
Consulting 
  
Manuscript preparation 
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Preparing an article for anonymous review 
  
To ensure a fair and unbiased review process, all submissions are to include an anonymised 
version of the manuscript. The exceptions to this requirement are Editorials, 
Correspondence, Book reviews and Obituary submissions. 
  
Submitting a manuscript that needs additional blinding can slow down your review process, 
so please be sure to follow these simple guidelines as much as possible: 
• An anonymous version should not contain any author, affiliation or particular institutional 
details that will enable identification. 
• Please remove title page, acknowledgements, contact details, funding grants to a named 
person, and any running headers of author names. 
• Mask self-citations by referring to your own work in third person. 
  
General article format/layout 
Submitted manuscripts that are not in the correct format specified in these guidelines will be 
returned to the author(s) for correction prior to being sent for review, which will delay 
publication. 
General: 
• Manuscripts must be written in UK English (this includes spelling). 
• The manuscript must be in Microsoft Word or RTF document format. Text must be 1.5 line 
spaced, in 12-point Times New Roman font, and contain no unnecessary formatting (such as 
text in boxes). Pages and lines should be numbered consecutively. 
• Please make your article concise, even if it is below the word limit. 
• Qualifications, full affiliation (department, school/faculty, institution, city, country) and 
contact details of ALL authors must be provided in the manuscript and in the online 
submission process. 
• Abbreviations should be spelt out when first used and thereafter used consistently, e.g. 
'intravenous (IV)' or 'Department of Health (DoH)'. 
• Scientific measurements must be expressed in SI units except: blood pressure (mmHg) and 
haemoglobin (g/dL). 
• Litres is denoted with an uppercase L e.g. 'mL' for millilitres). 
• Units should be preceded by a space (except for % and ºC), e.g. '40 kg' and '20 cm' but 
'50%' and '19ºC'. 
• Please be sure to insert proper symbols e.g. µ not u for micro, a not a for alpha, b not B for 
beta, etc. 
• Numbers should be written as grouped per thousand-units, i.e. 4 000, 22 160. 
• Quotes should be placed in single quotation marks: i.e. The respondent stated: '...' 
• Round brackets (parentheses) should be used, as opposed to square brackets, which are 
reserved for denoting concentrations or insertions in direct quotes. 
If you wish material to be in a box, simply indicate this in the text. You may use the table 
format –this is the only exception. Please DO NOT use fill, format lines and so on. 
  
SAJCH is a Journal on child health, therefore for articles involving genetics, it is the 
responsibility of authors to apply the following: 
-               Please ensure that all genes are in italics, and proteins/enzymes/hormones are 
not. 
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-               Ensure that all genes are presented in the correct case e.g. TP53 not Tp53. 
**           NB: Copyeditors cannot be expected to pick up and correct errors wrt the above, 
although they will raise queries where concerned. 
-               Define all genes, proteins and related shorthand terms at first mention, e.g. 
‘188del11’ can be glossed as ‘an 11 bp deletion at nucleotide 188.’ 
-               Use the latest approved gene or protein symbol as appropriate: 
• Human Gene Mapping Workshop (HGMW): genetic notations and symbols 
• HUGO Gene Nomenclature Committee: approved gene symbols and nomenclature 
• OMIM: Online Mendelian Inheritance in Man (MIM) nomenclature and instructions 
• Bennet et al. Standardized human pedigree nomenclature: Update and assessment of the 
recommendations of the National Society of Genetic Counselors. J Genet Counsel 
2008;17:424-433: standard human pedigree nomenclature. 
  
Preparation notes by article type 
  
Research 
Guideline word limit: 3 000 words (excluding abstract and bibliography) 
Research articles describe the background, methods, results and conclusions of an original 
research study. The article should contain the following sections: introduction, methods, 
results, discussion and conclusion, and should include a structured abstract (see below). The 
introduction should be concise – no more than three paragraphs – on the background to the 
research question, and must include references to other relevant published studies that 
clearly lay out the rationale for conducting the study. Some common reasons for conducting 
a study are: to fill a gap in the literature, a logical extension of previous work, or to answer 
an important clinical question. If other papers related to the same study have been 
published previously, please make sure to refer to them specifically. Describe the study 
methods in as much detail as possible so that others would be able to replicate the study 
should they need to. Where appropriate, sample size calculations should be included to 
demonstrate that the study is not underpowered. Results should describe the study sample 
as well as the findings from the study itself, but all interpretation of findings must be kept in 
the discussion section, which should consider primary outcomes first before any secondary 
or tertiary findings or post-hoc analyses. The conclusion should briefly summarise the main 
message of the paper and provide recommendations for further study. 
• May include up to 6 illustrations or tables. 
• A  max of 20 - 25references 
  
Structured abstract 
• This should be no more than 250words, with the following recommended headings: 
o Background: why the study is being done and how it relates to other published work. 
o Objectives: what the study intends to find out 
o Methods: must include study design, number of participants, description of the intervention, 
primary and secondary outcomes, any specific analyses that were done on the data. 
o Results: first sentence must be brief population and sample description; outline the results 
according to the methods described. Primary outcomes must be described first, even if they 
are not the most significant findings of the study. 
o Conclusion: must be supported by the data, include recommendations for further 
study/actions. 
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o Please ensure that the structured abstract is complete, accurate and clear and has been 
approved by all authors. It should be able to be intelligible to the reader without referral to 
the main body of the article. 
o Do not include any references in the abstracts. 
  
Here is an example of a good abstract. 
  
Scientific letters/short reports 
  
These include case reports, side effects of drugs and brief or negative research findings. 
  
Guideline word limit: 1500 words 
• Abstract: unstructured, of about 100-150 words 
• May include only one illustration or table 
• A  maximum of 6 references 
  
  
Editorials 
Guideline word limit: 1 000 words 
These opinion or comment articles are usually commissioned but we are happy to consider 
and peer review unsolicited editorials. Editorials should be accessible and interesting to 
readers without specialist knowledge of the subject under discussion and should have an 
element of topicality (why is a comment on this issue relevant now?) There should be a 
clear message to the piece, supported by evidence. 
Please make clear the type of evidence that supports each key statement, e.g.: 
• expert opinion 
• personal clinical experience 
• observational studies 
• trials 
• systematic reviews. 
  
Review articles 
Review articlesshould always be discussed with the Editor prior to submission. 
  
Guideline word limit: 4 000 words 
  
These are welcome, but should be either commissioned or discussed with the Editor before 
submission. A review article should provide a clear, up-to-date account of the topic and be 
aimed at non-specialist hospital doctors and general practitioners. They should be aligned to 
practice in South and/or sub-Saharan Africa and not a precis of reviews published in the 
international literature 
Please ensure that your article includes: 
• Abstract: unstructured, of about 100-150 words, explaining the review and why it is 
important 
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• Methods: Outline the sources and selection methods, including search strategy and keywords 
used for identifying references from online bibliographic databases. Discuss the quality of 
evidence. 
• When writing: clarify the evidence you used for key statements and the strength of the 
evidence. Do not present statements or opinions without such evidence, or if you have to, 
say that there is little or no evidence and that this is opinion. Avoid specialist jargon and 
abbreviations, and provide advice specific to southern Africa. 
• Personal details: Please supply your qualifications, position and affiliations and MP number 
(used for CPD points); address, telephone number and fax number, and your e-mail address; 
and a short personal profile (50 words) and a few words about your current fields of interest. 
  
  
Correspondence (Letters to the Editor) 
Guideline word limit: 400 words 
Letters to the editor should relate either to a paper or article published by the SAJCH or to a 
topical issue of particular relevance to the journal’s readership 
• May include only one illustration or table 
• Must include a correspondence address. 
  
Obituaries 
Guideline word limit: 400 words 
Should be offered within the first year of the practitioner’s death, and may be accompanied 
by a photograph. 
  
Illustrations/photos/scans 
• If illustrations submitted have been published elsewhere, the author(s) should provide 
evidence of consent to republication obtained from the copyright holder. 
• Figures must be numbered in Arabic numerals and referred to in the text e.g. '(Fig. 1)'. 
• Each figure must have a caption/legend: Fig. 1. Description (any abbreviations in full). 
• All images must be of high enough resolution/quality for print. 
• All illustrations (graphs, diagrams, charts, etc.) must be in PDF form. 
• Ensure all graph axes are labelled appropriately, with a heading/description and units (as 
necessary) indicated. Do not include decimal places if not necessary e.g. 0; 1.0; 2.0; 3.0; 4.0 
etc. 
• Scans/photos showing a specific feature e.g. Intermediate magnification micrograph of a low 
malignant potential (LMP) mucinous ovarian tumour. (H&E stain). –include an arrow to show 
the tumour. 
• Each image must be attached individually as a 'supplementary file' upon submission (not 
solely embedded in the accompanying manuscript) and named Fig. 1, Fig. 2, etc. 
  
Tables 
• Tables should be constructed carefully and simply for intelligible data representation. 
Unnecessarily complicated tables are strongly discouraged. 
• Large tables will generally not be accepted for publication in their entirety. Please consider 
shortening and using the text to highlight specific important sections, or offer a large table as 
an addendum to the publication, but available in full on request from the author. 
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• Embed/include each table in the manuscript Word file - do not provide separately as 
supplementary files. 
• Number each table in Arabic numerals (Table 1, Table 2, etc.) consecutively as they are 
referred to in the text. 
• Tables must be cell-based (i.e. not constructed with text boxes or tabs) and editable. 
• Ensure each table has a concise title and column headings, and include units where 
necessary. 
• Footnotes must be indicated with consecutive use of the following symbols: * † ‡ § ¶ || then 
** †† ‡‡ etc. 
  
Do not: Use [Enter] within a row to make ‘new rows’: 
  
Rather: 
Each row of data must have its own proper row: 
  
Do not: use separate columns for n and %: 
  
Rather: 
Combine into one column, n (%): 
  
Do not: have overlapping categories, e.g.: 
  
Rather: 
Use <> symbols or numbers that don’t overlap: 
  
  
References 
NB: Only complete, correctly formatted reference lists in Vancouver style will be accepted. 
If reference manager software is used, the reference list and citations in text are to be 
unformatted to plain text before submitting.. 
• Authors must verify references from original sources. 
• Citations should be inserted in the text as superscript numbers between square brackets, e.g. 
These regulations are endorsed by the World Health Organization,[2] and others.[3,4-6] 
• All references should be listed at the end of the article in numerical order of appearance in 
the Vancouver style (not alphabetical order). 
• Approved abbreviations of journal titles must be used; see the List of Journals in Index 
Medicus. 
• Names and initials of all authors should be given; if there are more than six authors, the first 
three names should be given followed by et al. 
• Volume and issue numbers should be given. 
• First and last page, in full, should be given e.g.: 1215-1217 not 1215-17. 
• Wherever possible, references must be accompanied by a digital object identifier (DOI) link). 
Authors are encouraged to use the DOI lookup service offered by CrossRef: 
o On the Crossref homepage, paste the article title into the ‘Metadata search’ box. 
o Look for the correct, matching article in the list of results. 
o Click Actions > Cite 
o Alongside 'url =' copy the URL between { }. 
o Provide as follows, e.g.: https://doi.org/10.7196/07294.937.98x 
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Some examples: 
• Journal references: Price NC, Jacobs NN, Roberts DA, et al. Importance of asking about 
glaucoma. Stat Med 1998;289(1):350-355. http://dx/doi.org/10.1000/hgjr.182 
• Book references: Jeffcoate N. Principles of Gynaecology. 4th ed. London: Butterworth, 
1975:96-101. 
• Chapter/section in a book: Weinstein L, Swartz MN. Pathogenic Properties of Invading 
Microorganisms. In: Sodeman WA, Sodeman WA, eds. Pathologic Physiology: Mechanisms of 
Disease. Philadelphia: WB Saunders, 1974:457-472. 
• Internet references: World Health Organization. The World Health Report 2002 - Reducing 
Risks, Promoting Healthy Life. Geneva: WHO, 2002. http://www.who.int/whr/2002 (accessed 
16 January 2010). 
• Legal references 
• Government Gazettes: 
National Department of Health, South Africa. National Policy for Health Act, 1990 (Act No. 
116 of 1990). Free primary health care services. Government Gazette No. 17507:1514. 
1996. 
In this example, 17507 is the Gazette Number. This is followed by :1514 - this is the notice 
number in this Gazette. 
• Provincial Gazettes: 
Gauteng Province, South Africa; Department of Agriculture, Conservation, Environment and 
Land Affairs. Publication of the Gauteng health care waste management draft regulations. 
Gauteng Provincial Gazette No. 373:3003, 2003. 
• Acts: 
South Africa. National Health Act No. 61 of 2003. 
• Regulations to an Act: 
South Africa. National Health Act of 2003. Regulations: Rendering of clinical forensic 
medicine services. Government Gazette No. 35099, 2012. (Published under Government 
Notice R176). 
• Bills: 
South Africa. Traditional Health Practitioners Bill, No. B66B-2003, 2006. 
• Green/white papers: 
South Africa. Department of Health Green Paper: National Health Insurance in South Africa. 
2011. 
• Case law: 
Rex v Jopp and Another 1949 (4) SA 11 (N) 
Rex v Jopp and Another:  Name of the parties concerned 
1949: Date of decision (or when the case was heard) 
(4): Volume number 
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SA: SA Law Reports 
11: Page or section number 
(N): In this case Natal - where the case was heard. Similarly, (C) woud indicate Cape, (G) 
Gauteng, and so on. 
NOTE: no . after the v 
• Other references (e.g. reports) should follow the same format: Author(s). Title. Publisher 
place: Publisher name, year; pages. 
• Cited manuscripts that have been accepted but not yet published can be included as 
references followed by '(in press)'. 
• Unpublished observations and personal communications in the text must not appear in the 
reference list. The full name of the source person must be provided for personal 
communications e.g. '...(Prof. Michael Jones, personal communication)'. 
  
From submission to acceptance 
Submission and peer-review 
To submit an article: 
• Please ensure that you have prepared your manuscript in line with the SAJCH requirements. 
• All submissions should be submitted via Editorial Manager 
• The following are required for your submission to be complete: 
o Anonymous manuscript (unless otherwise stated) 
o Author Agreement form [forthcoming] 
o Manuscript 
o Any supplementary files: figures, datasets, patient consent form, permissions for published 
images, etc. 
o Once the submission has been successfully processed on Editorial Manager, it will undergo a 
technical check by the Editorial Office before it will be assigned to an editor who will handle 
the review process. If the author guidelines have not been appropriately followed, the 
manuscript may be sent back to the author for correcting. 
  
Peer Review Process 
  
All manuscripts are reviewed initially by the Editor-in-Chief and only those that meet the 
scientific and editorial standards of the journal, and fit within the aims and scope of the 
journal, will be sent for external peer review. Each manuscript is reviewed by either one or 
two reviewers selected on the basis of their expertise in the field. A double blind review 
process is followed at SAJCH. 
Authors are expected to receive feedback from reviewers and an editorial decision within 
approximately 6 weeks of submission. The time period of the entire review process may 
vary however depending upon the quality of the manuscript submitted, reviewers’ responses 
and the time taken by the authors to submit the revised manuscript. 
Manuscripts from review may be accepted, rejected or returned to the author for revision or 
resubmission for review. Authors will be directed to submit revised manuscripts within two 
months of receiving the editor’s decision, and are requested to submit a point by point 
response to the reviewers’ comments. Manuscripts which authors are requested to revise 
and resubmit will be sent for a second round of peer review, often to the original set of 
reviewers. All final decisions on a manuscript are at the Editor's discretion. 
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Article Processing Charges 
There is currently no article-processing charge (APC), also known as page fees, for the 
publication of manuscripts.  
Please refer to the section on ‘Sponsored Supplements’ regarding the publication of 
supplements, where a charge is currently applicable. Queries can be directed 
to Dianes@hmpg.co.za or Claudian@hmpg.co.za 
  
Production process 
The following process should usually take between 4 - 6 weeks: 
1. An accepted manuscript is passed to a Managing Editor to assign to a copyeditor (CE). 
2. The CE copyedits in Word, working on house style, format, 
spelling/grammar/punctuation, sense and consistency, and preparation for 
typesetting. 
3. If the CE has an author queries, he/she will contact the corresponding author and 
send them the copyedited Word doc, asking them to solve the queries by means of 
track changes or comment boxes. 
4. The authors are typically asked to respond within 1-3 days. Any comments/changes 
must be clearly indicated e.g. by means of track changes. Do not work in the original 
manuscript - work in the copyedited file sent to you and make your changes clear. 
5. The CE will finalise the article and then it will be typeset. 
6. Once typeset, the CE will send a PDF of the file to the authors to complete their final 
check, while simultaneously sending to the 2nd-eye proofreader. 
7. The authors are typically asked to complete their final check and sign-off within 1-2 
days. No major additional changes can be accommodated at this point. 
8. The CE implements the authors’ and proofreader’s mark-ups, finalises the file, and 
prepares it for the upcoming issue. 
  
Changing contact details or authorship 
Please notify the Editorial Department of any contact detail changes, including email, to 
facilitate communication. 
  
Errata and retractions 
Errata 
Should you become aware of an error or inaccuracy in yours or someone else’s contribution 
after it has been published, please inform us as soon as possible via an email 
to publishing@hmpg.co.za,including the following details: 
• Journal, volume and issue in which published 
• Article title and authors 
• Description of error and details of where it appears in the published article 
• Full detail of proposed correction and rationale 
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We will investigate the issue and provide feedback. If appropriate, we will correct the web 
version immediately, and will publish anerratum in the next issue. All investigations will be 
conducted in accordance with guidelines provided by the Committee on Publication Ethics 
(COPE). 
  
Retractions 
Retraction of an article is the prerogative of either the original authors or the editorial team 
of HMPG. Should you wish to withdraw your article before publication, we need a signed 
statement from all the authors. 
  
Should you wish to retract your published article, all authors have to agree in writing before 
publication of the retraction. 
Send an email to publishing@hmpg.co.za, including the following details: 
• Journal, volume and issue to which article was submitted/in which article was published 
• Article title and authors 
• Description of reason for withdrawal/retraction. 
  
We will make a decision on a case-by-case basis upon review by the editorial committee in 
line with international best practices. Comprehensive feedback will be communicated with 
the authors with regard to the process. In case where there is any suspected fraud or 
professional misconduct, we will follow due process as recommended by the Committee on 
Publication Ethics (COPE), and in liaison with any relevant institutions. 
  
When a retraction is published, it will be linked to the original article. 
  
Indexing 
Published articles are covered by the following major indexing services. As such articles 
published in the SAJCH are immediately available to all users of these databases, 
guaranteed a global and African audience: 
• DOAJ 
• AIM 
• AJOL 
• Crossref 
• Sabinet 
• Scielo 
• EBSCO 
• EMBASE 
  
Sponsored supplements 
Contact claudian@hmpg.co.za for information on submitting ad hoc/commissioned 
supplements, including guidelines, conference/congress abstracts, Festschrifts, etc. 
  
. 
  
Submission Preparation Checklist 
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As part of the submission process, authors are required to check off their submission's 
compliance with all of the following items, and submissions may be returned to authors that 
do not adhere to these guidelines. 
1. Named authors consent to publication and meet the requirements of authorship as set 
out by the journal. 
2. The submission has not been previously published, nor is it before another journal for 
consideration. 
3. The text complies with the stylistic and bibliographic requirements in Author 
Guidelines. 
4. The manuscript is in Microsoft Word or RTF document format. The text is single-
spaced, in 12-point Times New Roman font, and contains no unnecessary formatting. 
5. Illustrations/figures are high resolution/quality (not compressed) and in an acceptable 
format (preferably TIFF or PNG). These must be submitted as 'supplementary files' 
(not in the manuscript). 
6. For illustrations/figures or tables that have been published elsewhere, the author has 
obtained written consent to republication from the copyright holder. 
7. Where possible, references are accompanied by a digital object identifier (DOI) and 
PubMed ID (PMID)/PubMed Central ID (PMCID). 
8. An abstract has been included where applicable. 
9. The research was approved by a Research Ethics Committee (if applicable) 
10. Any conflict of interest (or competing interests) is indicated by the author(s). 
  
Copyright Notice 
Copyright of published material remains in the Authors’ name. This allows authors to use 
their work for their own non-commercial purposes without seeking permission from the 
Publisher, subject to properly acknowledging the Journal as the original place of publication. 
 Authors are free to copy, print and distribute their articles, in full or in part, for teaching 
activities, and to deposit or include their work in their own personal or institutional database 
or on-line website. Authors are requested to inform the Journal/Publishers of their 
desire/intention to include their work in a thesis or dissertation or to republish their work in 
any derivative form (but not for commercial use).  
 Material submitted for publication in the SAJCH is accepted provided it has not been 
published or submitted for publication elsewhere. Please inform the editorial team if the 
main findings of your paper have been presented at a conference and published in abstract 
form, to avoid copyright infringement. 
  
Privacy Statement 
The SAJCH is committed to protecting the privacy of the users of this journal website. The 
names, personal particulars and email addresses entered in this website will be used only 
for the stated purposes of this journal and will not be made available to third parties without 
the user’s permission or due process. Users consent to receive communication from 
the SAJCH for the stated purposes of the journal. Queries with regard to privacy may be 
directed to publishing@hmpg.co.za. 
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